ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
R-HSA-909733,Interferon alpha/beta signaling,5/12,72/10899,8.348717226936925e-9,8.849640260553141e-7,4.3940616983878556e-7,BST2/HLA-F/IFITM3/ISG20/IRF1,5
R-HSA-913531,Interferon Signaling,6/12,200/10899,2.9867230660469916e-8,1.5829632250049056e-6,7.859797542228926e-7,BST2/SP100/HLA-F/IFITM3/ISG20/IRF1,6
R-HSA-877300,Interferon gamma signaling,3/12,92/10899,1.2119041322318048e-4,0.004282061267219044,0.0021261476004066754,SP100/HLA-F/IRF1,3
R-HSA-1236977,Endosomal/Vacuolar pathway,1/12,11/10899,0.012050248069853886,0.08044455007112002,0.03994267630144987,HLA-F,1
R-HSA-1839122,Signaling by activated point mutants of FGFR1,1/12,11/10899,0.012050248069853886,0.08044455007112002,0.03994267630144987,FGF20,1
R-HSA-1839130,Signaling by activated point mutants of FGFR3,1/12,12/10899,0.013139097906661346,0.08044455007112002,0.03994267630144987,FGF20,1
R-HSA-190373,FGFR1c ligand binding and activation,1/12,12/10899,0.013139097906661346,0.08044455007112002,0.03994267630144987,FGF20,1
R-HSA-2033514,FGFR3 mutant receptor activation,1/12,12/10899,0.013139097906661346,0.08044455007112002,0.03994267630144987,FGF20,1
R-HSA-190239,FGFR3 ligand binding and activation,1/12,13/10899,0.014226847592076708,0.08044455007112002,0.03994267630144987,FGF20,1
R-HSA-190372,FGFR3c ligand binding and activation,1/12,13/10899,0.014226847592076708,0.08044455007112002,0.03994267630144987,FGF20,1
R-HSA-190375,FGFR2c ligand binding and activation,1/12,13/10899,0.014226847592076708,0.08044455007112002,0.03994267630144987,FGF20,1
R-HSA-2168880,Scavenging of heme from plasma,1/12,13/10899,0.014226847592076708,0.08044455007112002,0.03994267630144987,HP,1
R-HSA-5654227,Phospholipase C-mediated cascade; FGFR3,1/12,13/10899,0.014226847592076708,0.08044455007112002,0.03994267630144987,FGF20,1
R-HSA-190322,FGFR4 ligand binding and activation,1/12,14/10899,0.015313498136711678,0.08044455007112002,0.03994267630144987,FGF20,1
R-HSA-2162123,Synthesis of Prostaglandins (PG) and Thromboxanes (TX),1/12,15/10899,0.01639905055034141,0.08044455007112002,0.03994267630144987,PTGS1,1
R-HSA-5654228,Phospholipase C-mediated cascade; FGFR4,1/12,15/10899,0.01639905055034141,0.08044455007112002,0.03994267630144987,FGF20,1
R-HSA-190242,FGFR1 ligand binding and activation,1/12,16/10899,0.0174835058419065,0.08044455007112002,0.03994267630144987,FGF20,1
R-HSA-5654219,Phospholipase C-mediated cascade: FGFR1,1/12,16/10899,0.0174835058419065,0.08044455007112002,0.03994267630144987,FGF20,1
R-HSA-2033519,Activated point mutants of FGFR2,1/12,17/10899,0.018566865019513767,0.08044455007112002,0.03994267630144987,FGF20,1
R-HSA-5654221,Phospholipase C-mediated cascade; FGFR2,1/12,18/10899,0.019649129090434814,0.08044455007112002,0.03994267630144987,FGF20,1
R-HSA-5654704,SHC-mediated cascade:FGFR3,1/12,18/10899,0.019649129090434814,0.08044455007112002,0.03994267630144987,FGF20,1
R-HSA-5654710,PI-3K cascade:FGFR3,1/12,18/10899,0.019649129090434814,0.08044455007112002,0.03994267630144987,FGF20,1
R-HSA-190241,FGFR2 ligand binding and activation,1/12,20/10899,0.021810375937145632,0.08044455007112002,0.03994267630144987,FGF20,1
R-HSA-5654706,FRS-mediated FGFR3 signaling,1/12,20/10899,0.021810375937145632,0.08044455007112002,0.03994267630144987,FGF20,1
R-HSA-5654719,SHC-mediated cascade:FGFR4,1/12,20/10899,0.021810375937145632,0.08044455007112002,0.03994267630144987,FGF20,1
R-HSA-5654720,PI-3K cascade:FGFR4,1/12,20/10899,0.021810375937145632,0.08044455007112002,0.03994267630144987,FGF20,1
R-HSA-5654688,SHC-mediated cascade:FGFR1,1/12,21/10899,0.02288936072331682,0.08044455007112002,0.03994267630144987,FGF20,1
R-HSA-5654689,PI-3K cascade:FGFR1,1/12,21/10899,0.02288936072331682,0.08044455007112002,0.03994267630144987,FGF20,1
R-HSA-5654712,FRS-mediated FGFR4 signaling,1/12,22/10899,0.02396725442356673,0.08044455007112002,0.03994267630144987,FGF20,1
R-HSA-5655332,Signaling by FGFR3 in disease,1/12,22/10899,0.02396725442356673,0.08044455007112002,0.03994267630144987,FGF20,1
R-HSA-5654693,FRS-mediated FGFR1 signaling,1/12,23/10899,0.025044058041009065,0.08044455007112002,0.03994267630144987,FGF20,1
R-HSA-5654695,PI-3K cascade:FGFR2,1/12,23/10899,0.025044058041009065,0.08044455007112002,0.03994267630144987,FGF20,1
R-HSA-5654699,SHC-mediated cascade:FGFR2,1/12,23/10899,0.025044058041009065,0.08044455007112002,0.03994267630144987,FGF20,1
R-HSA-5654700,FRS-mediated FGFR2 signaling,1/12,25/10899,0.027194399035770478,0.08099210442118694,0.04021455035808687,FGF20,1
R-HSA-5654708,Downstream signaling of activated FGFR3,1/12,25/10899,0.027194399035770478,0.08099210442118694,0.04021455035808687,FGF20,1
R-HSA-5654716,Downstream signaling of activated FGFR4,1/12,27/10899,0.02934039171591507,0.08099210442118694,0.04021455035808687,FGF20,1
R-HSA-5620971,Pyroptosis,1/12,28/10899,0.030411759936978866,0.08099210442118694,0.04021455035808687,IRF1,1
R-HSA-5654732,Negative regulation of FGFR3 signaling,1/12,29/10899,0.031482044076502014,0.08099210442118694,0.04021455035808687,FGF20,1
R-HSA-5669034,TNFs bind their physiological receptors,1/12,29/10899,0.031482044076502014,0.08099210442118694,0.04021455035808687,TNFRSF11B,1
R-HSA-983170,"Antigen Presentation: Folding, assembly and peptide loading of class I MHC",1/12,29/10899,0.031482044076502014,0.08099210442118694,0.04021455035808687,HLA-F,1
R-HSA-5654696,Downstream signaling of activated FGFR2,1/12,30/10899,0.032551245131799744,0.08099210442118694,0.04021455035808687,FGF20,1
R-HSA-1839124,FGFR1 mutant receptor activation,1/12,31/10899,0.033619364099360616,0.08099210442118694,0.04021455035808687,FGF20,1
R-HSA-5654687,Downstream signaling of activated FGFR1,1/12,31/10899,0.033619364099360616,0.08099210442118694,0.04021455035808687,FGF20,1
R-HSA-5654733,Negative regulation of FGFR4 signaling,1/12,31/10899,0.033619364099360616,0.08099210442118694,0.04021455035808687,FGF20,1
R-HSA-1839126,FGFR2 mutant receptor activation,1/12,33/10899,0.0357523597531042,0.08130473486214765,0.04036977897822624,FGF20,1
R-HSA-5654726,Negative regulation of FGFR1 signaling,1/12,33/10899,0.0357523597531042,0.08130473486214765,0.04036977897822624,FGF20,1
R-HSA-192105,Synthesis of bile acids and bile salts,1/12,34/10899,0.03681723842814233,0.08130473486214765,0.04036977897822624,CH25H,1
R-HSA-5654727,Negative regulation of FGFR2 signaling,1/12,34/10899,0.03681723842814233,0.08130473486214765,0.04036977897822624,FGF20,1
R-HSA-5655302,Signaling by FGFR1 in disease,1/12,38/10899,0.04106598194762312,0.0888366140091439,0.044109540223010876,FGF20,1
R-HSA-5654741,Signaling by FGFR3,1/12,40/10899,0.04318390487199997,0.08975478267513719,0.04456543330443753,FGF20,1
R-HSA-9692916,SARS-CoV-1 activates/modulates innate immune responses,1/12,40/10899,0.04318390487199997,0.08975478267513719,0.04456543330443753,BST2,1
R-HSA-5654743,Signaling by FGFR4,1/12,41/10899,0.04424125758786146,0.09018410200602528,0.04477860079743064,FGF20,1
R-HSA-2173782,Binding and Uptake of Ligands by Scavenger Receptors,1/12,42/10899,0.0452975391230378,0.0905950782460756,0.04498266049954101,HP,1
R-HSA-5655253,Signaling by FGFR2 in disease,1/12,43/10899,0.046352750464156545,0.09098873239260359,0.045178119360776356,FGF20,1
R-HSA-109704,PI3K Cascade,1/12,44/10899,0.04740689259702591,0.09136601118699539,0.04536544746126881,FGF20,1
R-HSA-194068,Bile acid and bile salt metabolism,1/12,45/10899,0.04845996650663709,0.09172779374470591,0.04554508130323035,CH25H,1
R-HSA-6783783,Interleukin-10 signaling,1/12,47/10899,0.05056291359197074,0.09402927790787541,0.04668782418464519,CXCL10,1
R-HSA-112399,IRS-mediated signalling,1/12,48/10899,0.05161278873359443,0.09432682078898293,0.046835561464241775,FGF20,1
R-HSA-5654736,Signaling by FGFR1,1/12,50/10899,0.05370934712339526,0.09649475923864233,0.047911995649772755,FGF20,1
R-HSA-2428928,IRS-related events triggered by IGF1R,1/12,52/10899,0.05580165619062616,0.09740175744811612,0.04836234232776372,FGF20,1
R-HSA-2428924,IGF1R signaling cascade,1/12,53/10899,0.05684621967598713,0.09740175744811612,0.04836234232776372,FGF20,1
R-HSA-2404192,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),1/12,54/10899,0.05788972376633317,0.09740175744811612,0.04836234232776372,FGF20,1
R-HSA-74751,Insulin receptor signalling cascade,1/12,54/10899,0.05788972376633317,0.09740175744811612,0.04836234232776372,FGF20,1
R-HSA-5218859,Regulated Necrosis,1/12,57/10899,0.06101388943173425,0.10105425437130985,0.05017589591425514,IRF1,1
R-HSA-2142753,Arachidonic acid metabolism,1/12,59/10899,0.06309138745425202,0.10132859197198052,0.0503121112075375,PTGS1,1
R-HSA-380108,Chemokine receptors bind chemokines,1/12,59/10899,0.06309138745425202,0.10132859197198052,0.0503121112075375,CXCL10,1
R-HSA-1226099,Signaling by FGFR in disease,1/12,63/10899,0.06723374871690546,0.10636981140286535,0.052815199306288654,FGF20,1
R-HSA-9679506,SARS-CoV Infections,2/12,413/10899,0.07356534258604254,0.11467538697236043,0.05693911964863974,BST2/HLA-F,2
R-HSA-5654738,Signaling by FGFR2,1/12,73/10899,0.07751631080177379,0.1190830281882322,0.05912762074887398,FGF20,1
R-HSA-3108214,SUMOylation of DNA damage response and repair proteins,1/12,77/10899,0.08160016135336301,0.123130580137931,0.06113732876759236,SP100,1
R-HSA-2219530,Constitutive Signaling by Aberrant PI3K in Cancer,1/12,78/10899,0.08261853116150941,0.123130580137931,0.06113732876759236,FGF20,1
R-HSA-74752,Signaling by Insulin receptor,1/12,79/10899,0.08363586575406634,0.123130580137931,0.06113732876759236,FGF20,1
R-HSA-190236,Signaling by FGFR,1/12,87/10899,0.09173738937766684,0.13320771608263954,0.06614087193775549,FGF20,1
R-HSA-1236974,ER-Phagosome pathway,1/12,90/10899,0.09475849510869894,0.13573514164219036,0.06739580021955828,HLA-F,1
R-HSA-6798695,Neutrophil degranulation,2/12,482/10899,0.09611455945476573,0.1358419106960689,0.06744881365246719,HP/BST2,2
R-HSA-9692914,SARS-CoV-1-host interactions,1/12,95/10899,0.09977320820156166,0.13915736933375705,0.06909501953016736,BST2,1
R-HSA-5668541,TNFR2 non-canonical NF-kB pathway,1/12,102/10899,0.10675103239404904,0.14488769056537978,0.07194026343861956,TNFRSF11B,1
R-HSA-2219528,PI3K/AKT Signaling in Cancer,1/12,104/10899,0.10873557010731627,0.14488769056537978,0.07194026343861956,FGF20,1
R-HSA-1236975,Antigen processing-Cross presentation,1/12,105/10899,0.10972632260001791,0.14488769056537978,0.07194026343861956,HLA-F,1
R-HSA-211945,Phase I - Functionalization of compounds,1/12,106/10899,0.1107160654320355,0.14488769056537978,0.07194026343861956,PTGS1,1
R-HSA-6811558,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",1/12,106/10899,0.1107160654320355,0.14488769056537978,0.07194026343861956,FGF20,1
R-HSA-199418,Negative regulation of the PI3K/AKT network,1/12,113/10899,0.11761607323888756,0.15204028979661074,0.07549170297746315,FGF20,1
R-HSA-9705671,SARS-CoV-2 activates/modulates innate and adaptive immune responses,1/12,126/10899,0.1303003282723687,0.16640764815507328,0.08262544595584573,HLA-F,1
R-HSA-198933,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,1/12,134/10899,0.13802271923131904,0.17417152664904545,0.08648040052087659,HLA-F,1
R-HSA-9678108,SARS-CoV-1 Infection,1/12,141/10899,0.14472819570753692,0.18048457347057545,0.08961498186225196,BST2,1
R-HSA-8957322,Metabolism of steroids,1/12,154/10899,0.15705451731326392,0.19357882366518575,0.09611659566295222,CH25H,1
R-HSA-983231,Factors involved in megakaryocyte development and platelet production,1/12,168/10899,0.17014673812746828,0.20730522116680045,0.1029320859815295,IRF1,1
R-HSA-8978868,Fatty acid metabolism,1/12,177/10899,0.1784644562392843,0.2149685495609561,0.10673711497564851,PTGS1,1
R-HSA-3108232,SUMO E3 ligases SUMOylate target proteins,1/12,182/10899,0.18305232017795203,0.21801737009958333,0.10825092854994207,SP100,1
R-HSA-2990846,SUMOylation,1/12,188/10899,0.18852675079126735,0.22204261759860378,0.11024956186623822,SP100,1
R-HSA-375276,Peptide ligand-binding receptors,1/12,201/10899,0.20027284237073062,0.23178271123290453,0.11508575532914822,CXCL10,1
R-HSA-9705683,SARS-CoV-2-host interactions,1/12,202/10899,0.2011699003153511,0.23178271123290453,0.11508575532914822,HLA-F,1
R-HSA-5357801,Programmed Cell Death,1/12,210/10899,0.2083132273874898,0.2374322806782142,0.11789090401102989,IRF1,1
R-HSA-211859,Biological oxidations,1/12,222/10899,0.21891848369778344,0.2468655241698409,0.12257473891253272,PTGS1,1
R-HSA-1257604,PIP3 activates AKT signaling,1/12,267/10899,0.25753892050650773,0.28735921656515595,0.14268084238587686,FGF20,1
R-HSA-5673001,RAF/MAP kinase cascade,1/12,280/10899,0.2683654196166536,0.2963201508267217,0.14713016426351624,FGF20,1
R-HSA-5684996,MAPK1/MAPK3 signaling,1/12,286/10899,0.2733132893667275,0.2986722543595166,0.14829804089350382,FGF20,1
R-HSA-9694516,SARS-CoV-2 Infection,1/12,298/10899,0.28311713163663044,0.30622873421921254,0.15205001699067158,HLA-F,1
R-HSA-9006925,Intracellular signaling by second messengers,1/12,309/10899,0.2919973249087118,0.31264360040730754,0.1552351541247803,FGF20,1
R-HSA-418594,G alpha (i) signalling events,1/12,318/10899,0.2991878121192445,0.3171390808463992,0.1574672695364445,CXCL10,1
R-HSA-5683057,MAPK family signaling cascades,1/12,325/10899,0.30473406458780095,0.31981990936937527,0.1587983661218348,FGF20,1
R-HSA-373076,Class A/1 (Rhodopsin-like receptors),1/12,335/10899,0.3125875060303822,0.32484583960020114,0.16129386276077512,CXCL10,1
R-HSA-983169,Class I MHC mediated antigen processing & presentation,1/12,381/10899,0.34767678664822266,0.35780329499720004,0.17765804121012913,HLA-F,1
R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,1/12,433/10899,0.3853610890200512,0.3927718791935137,0.19502079403848743,FGF20,1
R-HSA-500792,GPCR ligand binding,1/12,467/10899,0.4089104330139389,0.41280481809026215,0.20496763559595937,CXCL10,1
R-HSA-449147,Signaling by Interleukins,1/12,473/10899,0.412979297301198,0.412979297301198,0.20505426876921448,CXCL10,1
HALLMARK_INTERFERON_ALPHA_RESPONSE,HALLMARK_INTERFERON_ALPHA_RESPONSE,7/10,97/4383,2.379093008231064e-10,4.044458113992808e-9,2.5043084297169093e-9,BST2/CXCL10/PLSCR1/IFITM3/ISG20/IRF1/TMEM140,7
HALLMARK_INTERFERON_GAMMA_RESPONSE,HALLMARK_INTERFERON_GAMMA_RESPONSE,6/10,200/4383,1.5106510287852478e-6,1.2840533744674606e-5,7.95079488834341e-6,BST2/CXCL10/PLSCR1/IFITM3/ISG20/IRF1,6
HALLMARK_APOPTOSIS,HALLMARK_APOPTOSIS,3/10,161/4383,0.004825646050939099,0.027345327621988227,0.016932091406803858,IFITM3/ISG20/IRF1,3
HALLMARK_IL2_STAT5_SIGNALING,HALLMARK_IL2_STAT5_SIGNALING,3/10,199/4383,0.008730799974710463,0.03009994224573611,0.018637735136678706,CXCL10/PLSCR1/IFITM3,3
HALLMARK_INFLAMMATORY_RESPONSE,HALLMARK_INFLAMMATORY_RESPONSE,3/10,200/4383,0.008852924189922385,0.03009994224573611,0.018637735136678706,BST2/CXCL10/IRF1,3
HALLMARK_IL6_JAK_STAT3_SIGNALING,HALLMARK_IL6_JAK_STAT3_SIGNALING,2/10,87/4383,0.015804810916004625,0.04478029759534644,0.027727738449130922,CXCL10/IRF1,2
HALLMARK_UV_RESPONSE_UP,HALLMARK_UV_RESPONSE_UP,2/10,158/4383,0.048052036888261075,0.11669780387149117,0.07225870208761065,HLA-F/IRF1,2
HALLMARK_COMPLEMENT,HALLMARK_COMPLEMENT,2/10,200/4383,0.07324569221075306,0.13835297417586687,0.08566747626988663,PLSCR1/IRF1,2
HALLMARK_TNFA_SIGNALING_VIA_NFKB,HALLMARK_TNFA_SIGNALING_VIA_NFKB,2/10,200/4383,0.07324569221075306,0.13835297417586687,0.08566747626988663,CXCL10/IRF1,2
HALLMARK_CHOLESTEROL_HOMEOSTASIS,HALLMARK_CHOLESTEROL_HOMEOSTASIS,1/10,74/4383,0.15671660513602437,0.26641822873124144,0.16496484751160462,PLSCR1,1
HALLMARK_BILE_ACID_METABOLISM,HALLMARK_BILE_ACID_METABOLISM,1/10,112/4383,0.22827261866225235,0.35278495611439,0.21844269728445204,CH25H,1
HALLMARK_APICAL_JUNCTION,HALLMARK_APICAL_JUNCTION,1/10,200/4383,0.3734576480867645,0.3734576480867645,0.2312431257503186,TNFRSF11B,1
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,1/10,200/4383,0.3734576480867645,0.3734576480867645,0.2312431257503186,TNFRSF11B,1
HALLMARK_ESTROGEN_RESPONSE_LATE,HALLMARK_ESTROGEN_RESPONSE_LATE,1/10,200/4383,0.3734576480867645,0.3734576480867645,0.2312431257503186,ISG20,1
HALLMARK_GLYCOLYSIS,HALLMARK_GLYCOLYSIS,1/10,200/4383,0.3734576480867645,0.3734576480867645,0.2312431257503186,ISG20,1
HALLMARK_HYPOXIA,HALLMARK_HYPOXIA,1/10,200/4383,0.3734576480867645,0.3734576480867645,0.2312431257503186,ISG20,1
HALLMARK_KRAS_SIGNALING_UP,HALLMARK_KRAS_SIGNALING_UP,1/10,200/4383,0.3734576480867645,0.3734576480867645,0.2312431257503186,CXCL10,1
BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,9/16,204/21728,5.131568939184721e-15,3.494598447584795e-12,1.5772822423599353e-12,BST2/SP100/CXCL10/HLA-F/PLSCR1/IFITM3/IRF1/TMEM140/CH25H,9
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,9/16,339/21728,5.121638057290869e-13,1.3150363626852202e-10,5.935398684660087e-11,DEPP1/BST2/SP100/CXCL10/ISG20/IRF1/TNFRSF11B/TMEM140/CH25H,9
RADAEVA_RESPONSE_TO_IFNA1_UP,RADAEVA_RESPONSE_TO_IFNA1_UP,6/16,47/21728,5.793111729890838e-13,1.3150363626852202e-10,5.935398684660087e-11,BST2/CXCL10/HLA-F/PLSCR1/IFITM3/IRF1,6
BROWNE_INTERFERON_RESPONSIVE_GENES,BROWNE_INTERFERON_RESPONSIVE_GENES,6/16,67/21728,5.341754597347311e-12,9.094337201983797e-10,4.104716690593197e-10,BST2/SP100/CXCL10/HLA-F/PLSCR1/ISG20,6
REACTOME_INTERFERON_ALPHA_BETA_SIGNALING,REACTOME_INTERFERON_ALPHA_BETA_SIGNALING,5/16,71/21728,1.3710845585796327e-9,1.8674171687854596e-7,8.428561918005322e-8,BST2/HLA-F/IFITM3/ISG20/IRF1,5
REACTOME_INTERFERON_SIGNALING,REACTOME_INTERFERON_SIGNALING,6/16,203/21728,4.575347027503735e-9,5.193018876216739e-7,2.3438619860194573e-7,BST2/SP100/HLA-F/IFITM3/ISG20/IRF1,6
BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP,BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP,6/16,286/21728,3.5380817614991423e-8,3.442048113687023e-6,1.5535637208387214e-6,BST2/SP100/CXCL10/IRF1/TMEM140/CH25H,6
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,6/16,300/21728,4.6984417755869434e-8,3.999548561468385e-6,1.805190787462352e-6,BST2/SP100/CXCL10/PLSCR1/IFITM3/ISG20,6
GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3,GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3,3/16,14/21728,1.1865794660600004e-7,8.978451293187337e-6,4.052411743737078e-6,IFITM3/ISG20/IRF1,3
XIE_ST_HSC_S1PR3_OE_UP,XIE_ST_HSC_S1PR3_OE_UP,5/16,188/21728,1.8589077581304764e-7,1.2659161832868543e-5,5.7136954249905165e-6,BST2/CXCL10/PLSCR1/IFITM3/ISG20,5
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP,GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP,5/16,219/21728,3.965475656774149e-7,2.4549899293301778e-5,1.1080563557684706e-5,BST2/SP100/CXCL10/IRF1/TMEM140,5
MARKEY_RB1_ACUTE_LOF_DN,MARKEY_RB1_ACUTE_LOF_DN,5/16,230/21728,5.054134460270281e-7,2.8682213062033844e-5,1.2945677740341422e-5,HP/SP100/CXCL10/ISG20/CH25H,5
ZHANG_INTERFERON_RESPONSE,ZHANG_INTERFERON_RESPONSE,3/16,24/21728,6.568349161556631e-7,3.4408044454000505e-5,1.5530023928538755e-5,IFITM3/ISG20/IRF1,3
BOYLAN_MULTIPLE_MYELOMA_PCA1_UP,BOYLAN_MULTIPLE_MYELOMA_PCA1_UP,4/16,126/21728,1.8589699685625483e-6,9.042561061364968e-5,4.0813476001523615e-5,HP/PLSCR1/IFITM3/ISG20,4
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP,4/16,137/21728,2.59565034859658e-6,1.1784252582628472e-4,5.3188063283522905e-5,CXCL10/HLA-F/PTGS1/TMEM140,4
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP,4/16,184/21728,8.365984992818094e-6,3.560772362568201e-4,1.607149748620318e-4,BST2/CXCL10/PTGS1/CH25H,4
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,5/16,428/21728,1.057878072270794e-5,4.2377351012730044e-4,1.9126959572945626e-4,DEPP1/BST2/CXCL10/IRF1/TNFRSF11B,5
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,5/16,453/21728,1.3919852347264053e-5,5.266344138048234e-4,2.376957242924622e-4,SP100/CXCL10/IFITM3/ISG20/TMEM140,5
WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING_PATHWAY,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING_PATHWAY,4/16,221/21728,1.722199766873048e-5,6.172726532844978e-4,2.7860517004262047e-4,HP/BST2/CXCL10/IFITM3,4
DER_IFN_GAMMA_RESPONSE_UP,DER_IFN_GAMMA_RESPONSE_UP,3/16,71/21728,1.8160780431272645e-5,6.183745736848336e-4,2.7910252031219013e-4,BST2/PLSCR1/IRF1,3
DER_IFN_ALPHA_RESPONSE_UP,DER_IFN_ALPHA_RESPONSE_UP,3/16,74/21728,2.0569843136621697e-5,6.629627598684422e-4,2.992273373237269e-4,BST2/PLSCR1/IRF1,3
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP,SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP,3/16,75/21728,2.1417299144061276e-5,6.629627598684422e-4,2.992273373237269e-4,CXCL10/ISG20/CH25H,3
QI_PLASMACYTOMA_UP,QI_PLASMACYTOMA_UP,4/16,254/21728,2.971890160563882e-5,8.799379127582625e-4,3.9715877660624876e-4,SP100/PLSCR1/IRF1/PTGS1,4
KIM_GLIS2_TARGETS_UP,KIM_GLIS2_TARGETS_UP,3/16,85/21728,3.118707561841354e-5,8.849332706724842e-4,3.994134245866997e-4,CXCL10/IFITM3/IRF1,3
REACTOME_INTERFERON_GAMMA_SIGNALING,REACTOME_INTERFERON_GAMMA_SIGNALING,3/16,93/21728,4.082723973045483e-5,0.001097401296153281,4.953105780613e-4,SP100/HLA-F/IRF1,3
BOYLAN_MULTIPLE_MYELOMA_C_D_DN,BOYLAN_MULTIPLE_MYELOMA_C_D_DN,4/16,280/21728,4.347848237355887e-5,0.001097401296153281,4.953105780613e-4,HP/PLSCR1/IFITM3/ISG20,4
HECKER_IFNB1_TARGETS,HECKER_IFNB1_TARGETS,3/16,95/21728,4.3509302490658714e-5,0.001097401296153281,4.953105780613e-4,CXCL10/PLSCR1/TMEM140,3
LY_AGING_MIDDLE_UP,LY_AGING_MIDDLE_UP,2/16,14/21728,4.602502527508774e-5,0.0011193943647262413,5.052371195611137e-4,TNFRSF11B/PTGS1,2
DER_IFN_BETA_RESPONSE_UP,DER_IFN_BETA_RESPONSE_UP,3/16,103/21728,5.539185202764893e-5,0.0012573950410276306,5.675235365639821e-4,BST2/PLSCR1/IRF1,3
WIELAND_UP_BY_HBV_INFECTION,WIELAND_UP_BY_HBV_INFECTION,3/16,103/21728,5.539185202764893e-5,0.0012573950410276306,5.675235365639821e-4,CXCL10/HLA-F/ISG20,3
WALLACE_PROSTATE_CANCER_RACE_UP,WALLACE_PROSTATE_CANCER_RACE_UP,4/16,303/21728,5.9113270267969776e-5,0.0012985850662092717,5.861145982426885e-4,HLA-F/IFITM3/ISG20/IRF1,4
ZHU_CMV_ALL_UP,ZHU_CMV_ALL_UP,3/16,107/21728,6.205627875620577e-5,0.001320635182280504,5.960668880530291e-4,SP100/CXCL10/IRF1,3
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP,3/16,118/21728,8.303986626717331e-5,0.0017074421247468843,7.706516738945671e-4,CXCL10/IRF1/PTGS1,3
YANG_BCL3_TARGETS_UP,YANG_BCL3_TARGETS_UP,4/16,333/21728,8.524674337943328e-5,0.0017074421247468843,7.706516738945671e-4,HP/CXCL10/TMEM140/CH25H,4
RASHI_RESPONSE_TO_IONIZING_RADIATION_2,RASHI_RESPONSE_TO_IONIZING_RADIATION_2,3/16,125/21728,9.854438343663373e-5,0.0019173921462956448,8.654123297292347e-4,HP/PLSCR1/IRF1,3
FERRARI_RESPONSE_TO_FENRETINIDE_UP,FERRARI_RESPONSE_TO_FENRETINIDE_UP,2/16,22/21728,1.1643195526073413e-4,0.0022025044870155543,9.940973957934026e-4,DEPP1/IRF1,2
YAN_ESCAPE_FROM_ANOIKIS,YAN_ESCAPE_FROM_ANOIKIS,2/16,23/21728,1.2746595208203813e-4,0.002346062523455891,0.0010588921197142286,CXCL10/IRF1,2
BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,4/16,378/21728,1.3902997518708366e-4,0.0024915635026948415,0.001124563788216854,SP100/PLSCR1/IRF1/TMEM140,4
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP,BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP,3/16,144/21728,1.4985619492878958e-4,0.002571040889412047,0.001160435798297114,BST2/PLSCR1/IFITM3,3
WONG_ENDMETRIUM_CANCER_UP,WONG_ENDMETRIUM_CANCER_UP,2/16,25/21728,1.510156175866107e-4,0.002571040889412047,0.001160435798297114,HP/BST2,2
BROCKE_APOPTOSIS_REVERSED_BY_IL6,BROCKE_APOPTOSIS_REVERSED_BY_IL6,3/16,146/21728,0.00015609209745315339,0.0025926516674535964,0.001170189793487055,DEPP1/PLSCR1/IRF1,3
JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN,4/16,402/21728,1.7612373239673108e-4,0.002795846546760083,0.0012619015250853146,DEPP1/CXCL10/IFITM3/ISG20,4
EINAV_INTERFERON_SIGNATURE_IN_CANCER,EINAV_INTERFERON_SIGNATURE_IN_CANCER,2/16,27/21728,1.765365660949832e-4,0.002795846546760083,0.0012619015250853146,BST2/SP100,2
BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS,BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS,2/16,29/21728,2.0402367032615684e-4,0.0031577299884571093,0.0014252371228525788,PLSCR1/IFITM3,2
FOSTER_TOLERANT_MACROPHAGE_UP,FOSTER_TOLERANT_MACROPHAGE_UP,3/16,167/21728,2.3201071764612164e-4,0.0035110955270446407,0.0015847281766705854,HP/BST2/ISG20,3
TSAI_RESPONSE_TO_RADIATION_THERAPY,TSAI_RESPONSE_TO_RADIATION_THERAPY,2/16,32/21728,2.4892967545558605e-4,0.0036852414996794373,0.0016633287238679891,BST2/TNFRSF11B,2
MITSIADES_RESPONSE_TO_APLIDIN_UP,MITSIADES_RESPONSE_TO_APLIDIN_UP,4/16,445/21728,2.598137257126318e-4,0.0037579265901599877,0.0016961350403071587,PLSCR1/IFITM3/ISG20/IRF1,4
ROZANOV_MMP14_TARGETS_SUBSET,ROZANOV_MMP14_TARGETS_SUBSET,2/16,33/21728,2.6487588300687137e-4,0.0037579265901599877,0.0016961350403071587,TNFRSF11B/PTGS1,2
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PINK_DN,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PINK_DN,2/16,34/21728,2.8130979772705584e-4,0.003909632086778062,0.0017646071092653128,DEPP1/TMEM140,2
GHANDHI_DIRECT_IRRADIATION_DN,GHANDHI_DIRECT_IRRADIATION_DN,2/16,35/21728,2.9823078302747757e-4,0.004061903264834244,0.0018333344977689147,DEPP1/IRF1,2
WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,2/16,36/21728,3.1563820289384027e-4,0.004214698356288338,0.001902298353869997,BST2/IFITM3,2
WP_TYPE_II_INTERFERON_SIGNALING_IFNG,WP_TYPE_II_INTERFERON_SIGNALING_IFNG,2/16,37/21728,3.33531421885791e-4,0.0043679788135427625,0.001971481279162975,CXCL10/IRF1,2
ZHU_CMV_8_HR_UP,ZHU_CMV_8_HR_UP,2/16,41/21728,4.099496003666049e-4,0.005267465619804867,0.002377463422185673,SP100/CXCL10,2
BOQUEST_STEM_CELL_DN,BOQUEST_STEM_CELL_DN,3/16,218/21728,5.065415528230563e-4,0.006388051805046321,0.002883238468310574,BST2/HLA-F/ISG20,3
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2,2/16,47/21728,5.390431763547479e-4,0.006580792731725442,0.002970231822650636,BST2/ISG20,2
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,3/16,223/21728,5.411518252226501e-4,0.006580792731725442,0.002970231822650636,CXCL10/ISG20/IRF1,3
BURTON_ADIPOGENESIS_7,BURTON_ADIPOGENESIS_7,2/16,50/21728,6.100629058012089e-4,0.007162979980183159,0.0032330012430844463,IFITM3/PTGS1,2
SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION,SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION,2/16,50/21728,6.100629058012089e-4,0.007162979980183159,0.0032330012430844463,IRF1/TNFRSF11B,2
STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN,STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN,2/16,51/21728,6.346909117137685e-4,0.007243069608153865,0.0032691495874193196,BST2/SP100,2
BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING,BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING,3/16,236/21728,6.381559126126754e-4,0.007243069608153865,0.0032691495874193196,SP100/PLSCR1/ISG20,3
BECKER_TAMOXIFEN_RESISTANCE_UP,BECKER_TAMOXIFEN_RESISTANCE_UP,2/16,54/21728,7.114304413920519e-4,0.007942362796524383,0.003584774614089373,BST2/IFITM3,2
ROZANOV_MMP14_TARGETS_UP,ROZANOV_MMP14_TARGETS_UP,3/16,267/21728,9.12676990744881e-4,0.010024726301568773,0.00452464654155357,ISG20/TNFRSF11B/PTGS1,3
LEE_LIVER_CANCER_E2F1_UP,LEE_LIVER_CANCER_E2F1_UP,2/16,63/21728,9.672024775627447e-4,0.01029163886281608,0.004645117161978971,CXCL10/PLSCR1,2
LINDSTEDT_DENDRITIC_CELL_MATURATION_C,LINDSTEDT_DENDRITIC_CELL_MATURATION_C,2/16,63/21728,9.672024775627447e-4,0.01029163886281608,0.004645117161978971,DEPP1/TNFRSF11B,2
HADDAD_B_LYMPHOCYTE_PROGENITOR,HADDAD_B_LYMPHOCYTE_PROGENITOR,3/16,289/21728,0.0011469763201591389,0.011941691771193667,0.005389866291349487,DEPP1/HLA-F/ISG20,3
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,2/16,69/21728,0.0011588437850676987,0.011941691771193667,0.005389866291349487,IFITM3/PTGS1,2
POOLA_INVASIVE_BREAST_CANCER_UP,POOLA_INVASIVE_BREAST_CANCER_UP,3/16,292/21728,0.0011815992101497463,0.011941691771193667,0.005389866291349487,CXCL10/ISG20/CH25H,3
NATSUME_RESPONSE_TO_INTERFERON_BETA_UP,NATSUME_RESPONSE_TO_INTERFERON_BETA_UP,2/16,70/21728,0.0011924156247300577,0.011941691771193667,0.005389866291349487,IFITM3/IRF1,2
RAGHAVACHARI_PLATELET_SPECIFIC_GENES,RAGHAVACHARI_PLATELET_SPECIFIC_GENES,2/16,71/21728,0.0012264519970285736,0.012104547970673313,0.005463371214833615,PTGS1/TMEM140,2
FURUKAWA_DUSP6_TARGETS_PCI35_UP,FURUKAWA_DUSP6_TARGETS_PCI35_UP,2/16,73/21728,0.0012959158776220986,0.012429841023389425,0.00561019179044704,TAPBPL/HLA-F,2
GAURNIER_PSMD4_TARGETS,GAURNIER_PSMD4_TARGETS,2/16,73/21728,0.0012959158776220986,0.012429841023389425,0.00561019179044704,CXCL10/HLA-F,2
SANA_RESPONSE_TO_IFNG_UP,SANA_RESPONSE_TO_IFNG_UP,2/16,76/21728,0.0014035803209945636,0.013275530536073582,0.005991892598397845,BST2/CXCL10,2
LI_INDUCED_T_TO_NATURAL_KILLER_UP,LI_INDUCED_T_TO_NATURAL_KILLER_UP,3/16,315/21728,0.0014692270529608857,0.013706077028306344,0.006186219170361624,PLSCR1/IFITM3/TNFRSF11B,3
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP,2/16,83/21728,0.0016708984839565871,0.015171758234325811,0.006847752383372961,CXCL10/ISG20,2
SANA_TNF_SIGNALING_UP,SANA_TNF_SIGNALING_UP,2/16,83/21728,0.0016708984839565871,0.015171758234325811,0.006847752383372961,BST2/CXCL10,2
HINATA_NFKB_TARGETS_KERATINOCYTE_UP,HINATA_NFKB_TARGETS_KERATINOCYTE_UP,2/16,84/21728,0.0017109179623174546,0.015330725425502456,0.006919502008264499,CXCL10/IRF1,2
PHONG_TNF_RESPONSE_NOT_VIA_P38,PHONG_TNF_RESPONSE_NOT_VIA_P38,3/16,341/21728,0.0018435667171646073,0.016304791355702567,0.00735914533714375,SP100/CXCL10/IRF1,3
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,2/16,89/21728,0.001917842676165632,0.016744241826523017,0.007557490707697227,HLA-F/ISG20,2
COLINA_TARGETS_OF_4EBP1_AND_4EBP2,COLINA_TARGETS_OF_4EBP1_AND_4EBP2,3/16,359/21728,0.0021347906142634462,0.018172405103917585,0.008202090254801663,BST2/IFITM3/TNFRSF11B,3
GRUETZMANN_PANCREATIC_CANCER_UP,GRUETZMANN_PANCREATIC_CANCER_UP,3/16,359/21728,0.0021347906142634462,0.018172405103917585,0.008202090254801663,BST2/ISG20/PTGS1,3
GOLDRATH_ANTIGEN_RESPONSE,GOLDRATH_ANTIGEN_RESPONSE,3/16,366/21728,0.0022553679588005805,0.018961797283249322,0.008558381338138656,SP100/PLSCR1/IFITM3,3
CHYLA_CBFA2T3_TARGETS_UP,CHYLA_CBFA2T3_TARGETS_UP,3/16,387/21728,0.002642398054252432,0.021934961091228257,0.009900314767197852,DEPP1/HP/PTGS1,3
LINDGREN_BLADDER_CANCER_CLUSTER_2B,LINDGREN_BLADDER_CANCER_CLUSTER_2B,3/16,389/21728,0.0026812713460301857,0.021934961091228257,0.009900314767197852,IFITM3/ISG20/CH25H,3
BROWNE_HCMV_INFECTION_8HR_UP,BROWNE_HCMV_INFECTION_8HR_UP,2/16,106/21728,0.002705633967199961,0.021934961091228257,0.009900314767197852,CXCL10/ISG20,2
BASAKI_YBX1_TARGETS_DN,BASAKI_YBX1_TARGETS_DN,3/16,395/21728,0.002800025727102221,0.02243314729596015,0.010125170431131253,BST2/ISG20/PTGS1,3
TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,3/16,398/21728,0.002860610616532596,0.02265204453324067,0.010223969400581616,HP/HLA-F/IFITM3,3
BOSCO_TH1_CYTOTOXIC_MODULE,BOSCO_TH1_CYTOTOXIC_MODULE,2/16,114/21728,0.003120811024486666,0.024428417329602523,0.011025732839081748,CXCL10/CH25H,2
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,2/16,118/21728,0.003338929786037387,0.025650642321586314,0.011577382421985014,PLSCR1/PTGS1,2
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,3/16,421/21728,0.003352286588283674,0.025650642321586314,0.011577382421985014,DEPP1/BST2/ISG20,3
BAELDE_DIABETIC_NEPHROPATHY_DN,BAELDE_DIABETIC_NEPHROPATHY_DN,3/16,437/21728,0.0037232844011246672,0.02721160430913416,0.012281920485767333,BST2/SP100/PLSCR1,3
LIU_VMYB_TARGETS_UP,LIU_VMYB_TARGETS_UP,2/16,125/21728,0.0037373858244658057,0.02721160430913416,0.012281920485767333,PLSCR1/ISG20,2
MISSIAGLIA_REGULATED_BY_METHYLATION_UP,MISSIAGLIA_REGULATED_BY_METHYLATION_UP,2/16,125/21728,0.0037373858244658057,0.02721160430913416,0.012281920485767333,BST2/ISG20,2
ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION,ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION,2/16,126/21728,0.0037960387802756907,0.02721160430913416,0.012281920485767333,CXCL10/CH25H,2
CHEBOTAEV_GR_TARGETS_DN,CHEBOTAEV_GR_TARGETS_DN,2/16,126/21728,0.0037960387802756907,0.02721160430913416,0.012281920485767333,TNFRSF11B/CH25H,2
INGRAM_SHH_TARGETS_UP,INGRAM_SHH_TARGETS_UP,2/16,126/21728,0.0037960387802756907,0.02721160430913416,0.012281920485767333,PLSCR1/TMEM140,2
GAL_LEUKEMIC_STEM_CELL_UP,GAL_LEUKEMIC_STEM_CELL_UP,2/16,129/21728,0.003974580752005039,0.028194682209535745,0.012725631355103854,ISG20/TMEM140,2
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP,2/16,131/21728,0.0040957554772339975,0.028461321224452576,0.012845978510766137,ISG20/CH25H,2
WP_EBOLA_VIRUS_INFECTION_IN_HOST,WP_EBOLA_VIRUS_INFECTION_IN_HOST,2/16,131/21728,0.0040957554772339975,0.028461321224452576,0.012845978510766137,BST2/HLA-F,2
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,3/16,456/21728,0.004195540169930897,0.028860230865888292,0.013026025833278276,DEPP1/SP100/PLSCR1,3
SMID_BREAST_CANCER_NORMAL_LIKE_UP,SMID_BREAST_CANCER_NORMAL_LIKE_UP,3/16,484/21728,0.004955901361393746,0.033749688271091406,0.015232875763441832,DEPP1/ISG20/CH25H,3
PODAR_RESPONSE_TO_ADAPHOSTIN_UP,PODAR_RESPONSE_TO_ADAPHOSTIN_UP,2/16,148/21728,0.0051943921255249255,0.03502357462853935,0.015807842633176427,ISG20/TMEM140,2
SENESE_HDAC3_TARGETS_UP,SENESE_HDAC3_TARGETS_UP,3/16,495/21728,0.005276088187032403,0.03522564760165752,0.015899047993946973,DEPP1/CXCL10/TNFRSF11B,3
HUANG_GATA2_TARGETS_UP,HUANG_GATA2_TARGETS_UP,2/16,152/21728,0.0054705624658046926,0.03616944698265044,0.016325030557127952,DEPP1/HP,2
GROSS_HYPOXIA_VIA_ELK3_DN,GROSS_HYPOXIA_VIA_ELK3_DN,2/16,157/21728,0.005825128237117557,0.038143387783433236,0.017215966044922336,DEPP1/CXCL10,2
MIKKELSEN_MCV6_LCP_WITH_H3K4ME3,MIKKELSEN_MCV6_LCP_WITH_H3K4ME3,2/16,163/21728,0.006264230647473717,0.04034353054998744,0.018208997481407117,TAPBPL/ISG20,2
AMIT_EGF_RESPONSE_480_HELA,AMIT_EGF_RESPONSE_480_HELA,2/16,164/21728,0.006338851349263812,0.04034353054998744,0.018208997481407117,ISG20/PTGS1,2
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,2/16,164/21728,0.006338851349263812,0.04034353054998744,0.018208997481407117,CXCL10/PTGS1,2
ONDER_CDH1_TARGETS_1_DN,ONDER_CDH1_TARGETS_1_DN,2/16,170/21728,0.006795145910257487,0.04284717004523471,0.019339011752389734,DEPP1/SP100,2
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP,BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP,2/16,173/21728,0.007028777353011499,0.04312249889550298,0.019463281053384143,CXCL10/IFITM3,2
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP,2/16,173/21728,0.007028777353011499,0.04312249889550298,0.019463281053384143,CXCL10/IFITM3,2
NAGASHIMA_NRG1_SIGNALING_UP,NAGASHIMA_NRG1_SIGNALING_UP,2/16,173/21728,0.007028777353011499,0.04312249889550298,0.019463281053384143,ISG20/TNFRSF11B,2
HOFFMAN_CLOCK_TARGETS_UP,HOFFMAN_CLOCK_TARGETS_UP,1/16,10/21728,0.007340932248729781,0.04347108575117375,0.019620615255186234,TNFRSF11B,1
ISHIKAWA_STING_SIGNALING,ISHIKAWA_STING_SIGNALING,1/16,10/21728,0.007340932248729781,0.04347108575117375,0.019620615255186234,IRF1,1
IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS,IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS,1/16,10/21728,0.007340932248729781,0.04347108575117375,0.019620615255186234,ISG20,1
MARSHALL_VIRAL_INFECTION_RESPONSE_UP,MARSHALL_VIRAL_INFECTION_RESPONSE_UP,1/16,10/21728,0.007340932248729781,0.04347108575117375,0.019620615255186234,ISG20,1
JISON_SICKLE_CELL_DISEASE_UP,JISON_SICKLE_CELL_DISEASE_UP,2/16,182/21728,0.007751426618827211,0.04550622006397699,0.020539170351157404,BST2/CXCL10,2
REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY,REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY,1/16,11/21728,0.008072240153878862,0.0469845773059103,0.021206424875687163,HLA-F,1
FUNG_IL2_SIGNALING_2,FUNG_IL2_SIGNALING_2,1/16,12/21728,0.008803042942364114,0.05037707767857111,0.02273762529120143,TNFRSF11B,1
REACTOME_FGFR1C_LIGAND_BINDING_AND_ACTIVATION,REACTOME_FGFR1C_LIGAND_BINDING_AND_ACTIVATION,1/16,12/21728,0.008803042942364114,0.05037707767857111,0.02273762529120143,FGF20,1
KRIEG_KDM3A_TARGETS_NOT_HYPOXIA,KRIEG_KDM3A_TARGETS_NOT_HYPOXIA,2/16,200/21728,0.009293270818954721,0.05127654470494225,0.023143598506597324,IRF1/TMEM140,2
WIERENGA_STAT5A_TARGETS_UP,WIERENGA_STAT5A_TARGETS_UP,2/16,201/21728,0.009382654286011028,0.05127654470494225,0.023143598506597324,CXCL10/CH25H,2
BIOCARTA_PCAF_PATHWAY,BIOCARTA_PCAF_PATHWAY,1/16,13/21728,0.009533340939828161,0.05127654470494225,0.023143598506597324,IRF1,1
REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION,REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION,1/16,13/21728,0.009533340939828161,0.05127654470494225,0.023143598506597324,FGF20,1
REACTOME_FGFR3_LIGAND_BINDING_AND_ACTIVATION,REACTOME_FGFR3_LIGAND_BINDING_AND_ACTIVATION,1/16,13/21728,0.009533340939828161,0.05127654470494225,0.023143598506597324,FGF20,1
RUAN_RESPONSE_TO_TNF_UP,RUAN_RESPONSE_TO_TNF_UP,1/16,13/21728,0.009533340939828161,0.05127654470494225,0.023143598506597324,HP,1
SHIN_B_CELL_LYMPHOMA_CLUSTER_1,SHIN_B_CELL_LYMPHOMA_CLUSTER_1,1/16,13/21728,0.009533340939828161,0.05127654470494225,0.023143598506597324,IRF1,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP,2/16,203/21728,0.009562586163770434,0.05127654470494225,0.023143598506597324,CXCL10/CH25H,2
MANALO_HYPOXIA_UP,MANALO_HYPOXIA_UP,2/16,205/21728,0.009744067663293637,0.05184148498986693,0.023398583533566962,TAPBPL/PTGS1,2
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,2/16,207/21728,0.00992709442795003,0.05240582407313155,0.023653297208987425,TAPBPL/IRF1,2
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP,2/16,210/21728,0.01020452243683432,0.052948443751810445,0.02389820786077541,DEPP1/CXCL10,2
WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN,WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN,1/16,14/21728,0.010263134471716562,0.052948443751810445,0.02389820786077541,IRF1,1
WP_OSTEOBLAST_SIGNALING,WP_OSTEOBLAST_SIGNALING,1/16,14/21728,0.010263134471716562,0.052948443751810445,0.02389820786077541,TNFRSF11B,1
REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR4,REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR4,1/16,15/21728,0.010992423863282252,0.05536861802275759,0.024990550216624493,FGF20,1
REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX,REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX,1/16,15/21728,0.010992423863282252,0.05536861802275759,0.024990550216624493,PTGS1,1
WP_COVID19_ADVERSE_OUTCOME_PATHWAY,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,1/16,15/21728,0.010992423863282252,0.05536861802275759,0.024990550216624493,CXCL10,1
WANG_CISPLATIN_RESPONSE_AND_XPC_DN,WANG_CISPLATIN_RESPONSE_AND_XPC_DN,2/16,219/21728,0.011057462630095494,0.05536861802275759,0.024990550216624493,SP100/PTGS1,2
CAIRO_LIVER_DEVELOPMENT_DN,CAIRO_LIVER_DEVELOPMENT_DN,2/16,224/21728,0.011544599639993297,0.05577699821611848,0.025174872059829347,HP/ISG20,2
BIOCARTA_SPPA_PATHWAY,BIOCARTA_SPPA_PATHWAY,1/16,16/21728,0.011721209439581215,0.05577699821611848,0.025174872059829347,PTGS1,1
KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS,KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS,1/16,16/21728,0.011721209439581215,0.05577699821611848,0.025174872059829347,CH25H,1
KOINUMA_COLON_CANCER_MSI_UP,KOINUMA_COLON_CANCER_MSI_UP,1/16,16/21728,0.011721209439581215,0.05577699821611848,0.025174872059829347,CXCL10,1
REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION,REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION,1/16,16/21728,0.011721209439581215,0.05577699821611848,0.025174872059829347,FGF20,1
VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN,VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN,1/16,16/21728,0.011721209439581215,0.05577699821611848,0.025174872059829347,SP100,1
WP_OSTEOCLAST_SIGNALING,WP_OSTEOCLAST_SIGNALING,1/16,16/21728,0.011721209439581215,0.05577699821611848,0.025174872059829347,TNFRSF11B,1
BIOCARTA_PML_PATHWAY,BIOCARTA_PML_PATHWAY,1/16,17/21728,0.012449491525477252,0.05577699821611848,0.025174872059829347,SP100,1
BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX,BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX,1/16,17/21728,0.012449491525477252,0.05577699821611848,0.025174872059829347,IRF1,1
IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN,IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN,1/16,17/21728,0.012449491525477252,0.05577699821611848,0.025174872059829347,HLA-F,1
KORKOLA_TERATOMA_UP,KORKOLA_TERATOMA_UP,1/16,17/21728,0.012449491525477252,0.05577699821611848,0.025174872059829347,TAPBPL,1
LEI_HOXC8_TARGETS_DN,LEI_HOXC8_TARGETS_DN,1/16,17/21728,0.012449491525477252,0.05577699821611848,0.025174872059829347,CXCL10,1
LIU_VAV3_PROSTATE_CARCINOGENESIS_DN,LIU_VAV3_PROSTATE_CARCINOGENESIS_DN,1/16,17/21728,0.012449491525477252,0.05577699821611848,0.025174872059829347,PTGS1,1
LOPEZ_EPITHELIOID_MESOTHELIOMA,LOPEZ_EPITHELIOID_MESOTHELIOMA,1/16,17/21728,0.012449491525477252,0.05577699821611848,0.025174872059829347,HP,1
PIEPOLI_LGI1_TARGETS_UP,PIEPOLI_LGI1_TARGETS_UP,1/16,17/21728,0.012449491525477252,0.05577699821611848,0.025174872059829347,TNFRSF11B,1
RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP,RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP,1/16,17/21728,0.012449491525477252,0.05577699821611848,0.025174872059829347,HP,1
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN,AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN,1/16,18/21728,0.013177270445637101,0.05608575733424291,0.02531423006661864,PTGS1,1
BOWIE_RESPONSE_TO_TAMOXIFEN,BOWIE_RESPONSE_TO_TAMOXIFEN,1/16,18/21728,0.013177270445637101,0.05608575733424291,0.02531423006661864,IRF1,1
HAHTOLA_MYCOSIS_FUNGOIDES_UP,HAHTOLA_MYCOSIS_FUNGOIDES_UP,1/16,18/21728,0.013177270445637101,0.05608575733424291,0.02531423006661864,TMEM140,1
PODAR_RESPONSE_TO_ADAPHOSTIN_DN,PODAR_RESPONSE_TO_ADAPHOSTIN_DN,1/16,18/21728,0.013177270445637101,0.05608575733424291,0.02531423006661864,CXCL10,1
REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR2,REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR2,1/16,18/21728,0.013177270445637101,0.05608575733424291,0.02531423006661864,FGF20,1
REACTOME_PI_3K_CASCADE_FGFR3,REACTOME_PI_3K_CASCADE_FGFR3,1/16,18/21728,0.013177270445637101,0.05608575733424291,0.02531423006661864,FGF20,1
REACTOME_SHC_MEDIATED_CASCADE_FGFR3,REACTOME_SHC_MEDIATED_CASCADE_FGFR3,1/16,18/21728,0.013177270445637101,0.05608575733424291,0.02531423006661864,FGF20,1
WP_NEPHROGENESIS,WP_NEPHROGENESIS,1/16,18/21728,0.013177270445637101,0.05608575733424291,0.02531423006661864,FGF20,1
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,2/16,242/21728,0.013375662016117,0.05636307251909719,0.025439395897018904,PLSCR1/ISG20,2
DOANE_RESPONSE_TO_ANDROGEN_DN,DOANE_RESPONSE_TO_ANDROGEN_DN,2/16,243/21728,0.013480898138447502,0.05636307251909719,0.025439395897018904,PLSCR1/IFITM3,2
HOLLERN_PAPILLARY_BREAST_TUMOR,HOLLERN_PAPILLARY_BREAST_TUMOR,1/16,19/21728,0.013904546524534989,0.05636307251909719,0.025439395897018904,HP,1
RASHI_NFKB1_TARGETS,RASHI_NFKB1_TARGETS,1/16,19/21728,0.013904546524534989,0.05636307251909719,0.025439395897018904,IRF1,1
UROSEVIC_RESPONSE_TO_IMIQUIMOD,UROSEVIC_RESPONSE_TO_IMIQUIMOD,1/16,19/21728,0.013904546524534989,0.05636307251909719,0.025439395897018904,ISG20,1
VERNOCHET_ADIPOGENESIS,VERNOCHET_ADIPOGENESIS,1/16,19/21728,0.013904546524534989,0.05636307251909719,0.025439395897018904,HP,1
WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,1/16,19/21728,0.013904546524534989,0.05636307251909719,0.025439395897018904,PTGS1,1
XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR,XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR,1/16,19/21728,0.013904546524534989,0.05636307251909719,0.025439395897018904,PLSCR1,1
REACTOME_FGFR2_LIGAND_BINDING_AND_ACTIVATION,REACTOME_FGFR2_LIGAND_BINDING_AND_ACTIVATION,1/16,20/21728,0.014631320086449406,0.05759496519579217,0.025995408976228943,FGF20,1
REACTOME_FRS_MEDIATED_FGFR3_SIGNALING,REACTOME_FRS_MEDIATED_FGFR3_SIGNALING,1/16,20/21728,0.014631320086449406,0.05759496519579217,0.025995408976228943,FGF20,1
REACTOME_PI_3K_CASCADE_FGFR4,REACTOME_PI_3K_CASCADE_FGFR4,1/16,20/21728,0.014631320086449406,0.05759496519579217,0.025995408976228943,FGF20,1
REACTOME_SHC_MEDIATED_CASCADE_FGFR4,REACTOME_SHC_MEDIATED_CASCADE_FGFR4,1/16,20/21728,0.014631320086449406,0.05759496519579217,0.025995408976228943,FGF20,1
WP_ASPIRIN_AND_MIRNAS,WP_ASPIRIN_AND_MIRNAS,1/16,20/21728,0.014631320086449406,0.05759496519579217,0.025995408976228943,PTGS1,1
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,2/16,258/21728,0.015103067283102964,0.05875572910771109,0.02651931818448356,PLSCR1/PTGS1,2
REACTOME_PI_3K_CASCADE_FGFR1,REACTOME_PI_3K_CASCADE_FGFR1,1/16,21/21728,0.015357591455466335,0.05875572910771109,0.02651931818448356,FGF20,1
REACTOME_SHC_MEDIATED_CASCADE_FGFR1,REACTOME_SHC_MEDIATED_CASCADE_FGFR1,1/16,21/21728,0.015357591455466335,0.05875572910771109,0.02651931818448356,FGF20,1
STEGER_ADIPOGENESIS_UP,STEGER_ADIPOGENESIS_UP,1/16,21/21728,0.015357591455466335,0.05875572910771109,0.02651931818448356,HP,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP,1/16,21/21728,0.015357591455466335,0.05875572910771109,0.02651931818448356,CH25H,1
LU_AGING_BRAIN_UP,LU_AGING_BRAIN_UP,2/16,263/21728,0.015661786036202757,0.059584783746670825,0.026893510864870365,HP/TNFRSF11B,2
KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,2/16,265/21728,0.015887766336596013,0.060108715973454914,0.02712998696073705,CXCL10/TNFRSF11B,2
BIOCARTA_EICOSANOID_PATHWAY,BIOCARTA_EICOSANOID_PATHWAY,1/16,22/21728,0.016083360955476023,0.06018004841032512,0.027162182758814334,PTGS1,1
REACTOME_FRS_MEDIATED_FGFR4_SIGNALING,REACTOME_FRS_MEDIATED_FGFR4_SIGNALING,1/16,22/21728,0.016083360955476023,0.06018004841032512,0.027162182758814334,FGF20,1
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP,1/16,23/21728,0.01680862891017576,0.06088657599909411,0.027481073022235847,TNFRSF11B,1
REACTOME_FRS_MEDIATED_FGFR1_SIGNALING,REACTOME_FRS_MEDIATED_FGFR1_SIGNALING,1/16,23/21728,0.01680862891017576,0.06088657599909411,0.027481073022235847,FGF20,1
REACTOME_PI_3K_CASCADE_FGFR2,REACTOME_PI_3K_CASCADE_FGFR2,1/16,23/21728,0.01680862891017576,0.06088657599909411,0.027481073022235847,FGF20,1
WILLERT_WNT_SIGNALING,WILLERT_WNT_SIGNALING,1/16,23/21728,0.01680862891017576,0.06088657599909411,0.027481073022235847,TNFRSF11B,1
WP_HIPPOYAP_SIGNALING_PATHWAY,WP_HIPPOYAP_SIGNALING_PATHWAY,1/16,23/21728,0.01680862891017576,0.06088657599909411,0.027481073022235847,CXCL10,1
WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,1/16,23/21728,0.01680862891017576,0.06088657599909411,0.027481073022235847,IRF1,1
WP_IL18_SIGNALING_PATHWAY,WP_IL18_SIGNALING_PATHWAY,2/16,279/21728,0.017509110396580006,0.0628433812259453,0.028364274392110714,IRF1/TNFRSF11B,2
ODONNELL_METASTASIS_DN,ODONNELL_METASTASIS_DN,1/16,24/21728,0.01753339564306844,0.0628433812259453,0.028364274392110714,ISG20,1
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,2/16,282/21728,0.01786544794807781,0.06311404805153759,0.02848643949462706,TAPBPL/ISG20,2
HELLER_SILENCED_BY_METHYLATION_UP,HELLER_SILENCED_BY_METHYLATION_UP,2/16,283/21728,0.017984919592870546,0.06311404805153759,0.02848643949462706,CXCL10/ISG20,2
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP,DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP,1/16,25/21728,0.018257661477463882,0.06311404805153759,0.02848643949462706,IRF1,1
PETROVA_PROX1_TARGETS_UP,PETROVA_PROX1_TARGETS_UP,1/16,25/21728,0.018257661477463882,0.06311404805153759,0.02848643949462706,CH25H,1
REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC,REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC,1/16,25/21728,0.018257661477463882,0.06311404805153759,0.02848643949462706,HLA-F,1
REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3,1/16,25/21728,0.018257661477463882,0.06311404805153759,0.02848643949462706,FGF20,1
REACTOME_FRS_MEDIATED_FGFR2_SIGNALING,REACTOME_FRS_MEDIATED_FGFR2_SIGNALING,1/16,25/21728,0.018257661477463882,0.06311404805153759,0.02848643949462706,FGF20,1
BRACHAT_RESPONSE_TO_METHOTREXATE_DN,BRACHAT_RESPONSE_TO_METHOTREXATE_DN,1/16,26/21728,0.018981426736476514,0.06367660890414042,0.028740350568064,IFITM3,1
FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN,FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN,1/16,26/21728,0.018981426736476514,0.06367660890414042,0.028740350568064,IFITM3,1
NOJIMA_SFRP2_TARGETS_DN,NOJIMA_SFRP2_TARGETS_DN,1/16,26/21728,0.018981426736476514,0.06367660890414042,0.028740350568064,BST2,1
SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_UP,SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_UP,1/16,26/21728,0.018981426736476514,0.06367660890414042,0.028740350568064,IRF1,1
TIAN_TNF_SIGNALING_VIA_NFKB,TIAN_TNF_SIGNALING_VIA_NFKB,1/16,26/21728,0.018981426736476514,0.06367660890414042,0.028740350568064,IRF1,1
WP_EICOSANOID_SYNTHESIS,WP_EICOSANOID_SYNTHESIS,1/16,26/21728,0.018981426736476514,0.06367660890414042,0.028740350568064,PTGS1,1
HELLER_HDAC_TARGETS_DN,HELLER_HDAC_TARGETS_DN,2/16,293/21728,0.01919854905393345,0.0640892740476896,0.028926606417691268,TAPBPL/ISG20,2
ENK_UV_RESPONSE_EPIDERMIS_UP,ENK_UV_RESPONSE_EPIDERMIS_UP,2/16,296/21728,0.019569297627402626,0.06451391863943928,0.02911826917492275,PLSCR1/IFITM3,2
REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4,1/16,27/21728,0.019704691743029912,0.06451391863943928,0.02911826917492275,FGF20,1
REACTOME_PYROPTOSIS,REACTOME_PYROPTOSIS,1/16,27/21728,0.019704691743029912,0.06451391863943928,0.02911826917492275,IRF1,1
XU_AKT1_TARGETS_6HR,XU_AKT1_TARGETS_6HR,1/16,27/21728,0.019704691743029912,0.06451391863943928,0.02911826917492275,PLSCR1,1
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP,DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP,1/16,28/21728,0.020427456819851586,0.06547092182634752,0.02955021125789238,ISG20,1
PLASARI_NFIC_TARGETS_BASAL_UP,PLASARI_NFIC_TARGETS_BASAL_UP,1/16,28/21728,0.020427456819851586,0.06547092182634752,0.02955021125789238,TNFRSF11B,1
ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP,ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP,1/16,28/21728,0.020427456819851586,0.06547092182634752,0.02955021125789238,IFITM3,1
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,2/16,304/21728,0.02057283341312444,0.06547092182634752,0.02955021125789238,BST2/CXCL10,2
JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN,2/16,308/21728,0.02108265409641715,0.06547092182634752,0.02955021125789238,CXCL10/IFITM3,2
GILDEA_METASTASIS,GILDEA_METASTASIS,1/16,29/21728,0.02114972228947798,0.06547092182634752,0.02955021125789238,BST2,1
REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING,REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING,1/16,29/21728,0.02114972228947798,0.06547092182634752,0.02955021125789238,FGF20,1
REACTOME_TNFS_BIND_THEIR_PHYSIOLOGICAL_RECEPTORS,REACTOME_TNFS_BIND_THEIR_PHYSIOLOGICAL_RECEPTORS,1/16,29/21728,0.02114972228947798,0.06547092182634752,0.02955021125789238,TNFRSF11B,1
SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_PRE_TREATMENT_UP,SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_PRE_TREATMENT_UP,1/16,29/21728,0.02114972228947798,0.06547092182634752,0.02955021125789238,IFITM3,1
DOUGLAS_BMI1_TARGETS_DN,DOUGLAS_BMI1_TARGETS_DN,2/16,314/21728,0.02185736198336938,0.06547092182634752,0.02955021125789238,BST2/SP100,2
CHOW_RASSF1_TARGETS_DN,CHOW_RASSF1_TARGETS_DN,1/16,30/21728,0.0218714884742498,0.06547092182634752,0.02955021125789238,BST2,1
DAZARD_UV_RESPONSE_CLUSTER_G2,DAZARD_UV_RESPONSE_CLUSTER_G2,1/16,30/21728,0.0218714884742498,0.06547092182634752,0.02955021125789238,HLA-F,1
KAMIKUBO_MYELOID_CEBPA_NETWORK,KAMIKUBO_MYELOID_CEBPA_NETWORK,1/16,30/21728,0.0218714884742498,0.06547092182634752,0.02955021125789238,HP,1
PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION,PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION,1/16,30/21728,0.0218714884742498,0.06547092182634752,0.02955021125789238,IRF1,1
REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2,1/16,30/21728,0.0218714884742498,0.06547092182634752,0.02955021125789238,FGF20,1
TING_SILENCED_BY_DICER,TING_SILENCED_BY_DICER,1/16,30/21728,0.0218714884742498,0.06547092182634752,0.02955021125789238,DEPP1,1
WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,1/16,30/21728,0.0218714884742498,0.06547092182634752,0.02955021125789238,PTGS1,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,2/16,317/21728,0.02224917669244349,0.06547092182634752,0.02955021125789238,HLA-F/IRF1,2
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,2/16,319/21728,0.022512029633311132,0.06547092182634752,0.02955021125789238,TAPBPL/ISG20,2
BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP,BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP,1/16,31/21728,0.02259275569631669,0.06547092182634752,0.02955021125789238,HP,1
MOSERLE_IFNA_RESPONSE,MOSERLE_IFNA_RESPONSE,1/16,31/21728,0.02259275569631669,0.06547092182634752,0.02955021125789238,CXCL10,1
REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1,1/16,31/21728,0.02259275569631669,0.06547092182634752,0.02955021125789238,FGF20,1
REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION,REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION,1/16,31/21728,0.02259275569631669,0.06547092182634752,0.02955021125789238,FGF20,1
REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING,REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING,1/16,31/21728,0.02259275569631669,0.06547092182634752,0.02955021125789238,FGF20,1
TSENG_ADIPOGENIC_POTENTIAL_UP,TSENG_ADIPOGENIC_POTENTIAL_UP,1/16,31/21728,0.02259275569631669,0.06547092182634752,0.02955021125789238,CH25H,1
WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE,1/16,31/21728,0.02259275569631669,0.06547092182634752,0.02955021125789238,PTGS1,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5,1/16,31/21728,0.02259275569631669,0.06547092182634752,0.02955021125789238,ISG20,1
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,2/16,321/21728,0.022776192514017156,0.06572282670358341,0.029663908180611105,CXCL10/PLSCR1,2
PID_IL12_STAT4_PATHWAY,PID_IL12_STAT4_PATHWAY,1/16,32/21728,0.023313524277635334,0.06626321490573932,0.02990781165851438,IRF1,1
WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP,WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP,1/16,32/21728,0.023313524277635334,0.06626321490573932,0.02990781165851438,CXCL10,1
WP_MONOAMINE_TRANSPORT,WP_MONOAMINE_TRANSPORT,1/16,32/21728,0.023313524277635334,0.06626321490573932,0.02990781165851438,TNFRSF11B,1
APPEL_IMATINIB_RESPONSE,APPEL_IMATINIB_RESPONSE,1/16,33/21728,0.024033794539967124,0.06626321490573932,0.02990781165851438,PLSCR1,1
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN,1/16,33/21728,0.024033794539967124,0.06626321490573932,0.02990781165851438,TNFRSF11B,1
GREENBAUM_E2A_TARGETS_UP,GREENBAUM_E2A_TARGETS_UP,1/16,33/21728,0.024033794539967124,0.06626321490573932,0.02990781165851438,PTGS1,1
MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN,MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN,1/16,33/21728,0.024033794539967124,0.06626321490573932,0.02990781165851438,PLSCR1,1
REACTOME_FGFR2_MUTANT_RECEPTOR_ACTIVATION,REACTOME_FGFR2_MUTANT_RECEPTOR_ACTIVATION,1/16,33/21728,0.024033794539967124,0.06626321490573932,0.02990781165851438,FGF20,1
REACTOME_NEGATIVE_REGULATION_OF_FGFR1_SIGNALING,REACTOME_NEGATIVE_REGULATION_OF_FGFR1_SIGNALING,1/16,33/21728,0.024033794539967124,0.06626321490573932,0.02990781165851438,FGF20,1
WP_PROSTAGLANDIN_SIGNALING,WP_PROSTAGLANDIN_SIGNALING,1/16,33/21728,0.024033794539967124,0.06626321490573932,0.02990781165851438,CXCL10,1
WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,1/16,33/21728,0.024033794539967124,0.06626321490573932,0.02990781165851438,TNFRSF11B,1
GROSS_HYPOXIA_VIA_ELK3_ONLY_UP,GROSS_HYPOXIA_VIA_ELK3_ONLY_UP,1/16,34/21728,0.024753566804883498,0.06716007567380741,0.030312608542780378,CH25H,1
REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING,REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING,1/16,34/21728,0.024753566804883498,0.06716007567380741,0.030312608542780378,FGF20,1
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS,REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS,1/16,34/21728,0.024753566804883498,0.06716007567380741,0.030312608542780378,CH25H,1
VALK_AML_CLUSTER_6,VALK_AML_CLUSTER_6,1/16,34/21728,0.024753566804883498,0.06716007567380741,0.030312608542780378,BST2,1
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP,1/16,35/21728,0.02547284139376149,0.06829529523288022,0.03082498834222278,TNFRSF11B,1
NAKAMURA_ADIPOGENESIS_EARLY_DN,NAKAMURA_ADIPOGENESIS_EARLY_DN,1/16,35/21728,0.02547284139376149,0.06829529523288022,0.03082498834222278,TNFRSF11B,1
XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP,XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP,1/16,35/21728,0.02547284139376149,0.06829529523288022,0.03082498834222278,ISG20,1
NABA_SECRETED_FACTORS,NABA_SECRETED_FACTORS,2/16,343/21728,0.025767328085053526,0.06881392323890764,0.031059070385286394,FGF20/CXCL10,2
HAN_JNK_SINGALING_UP,HAN_JNK_SINGALING_UP,1/16,36/21728,0.026191618627786295,0.06913369102915684,0.031203397141222354,CXCL10,1
HOUSTIS_ROS,HOUSTIS_ROS,1/16,36/21728,0.026191618627786295,0.06913369102915684,0.031203397141222354,HP,1
SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM,SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM,1/16,36/21728,0.026191618627786295,0.06913369102915684,0.031203397141222354,ISG20,1
KEGG_ALLOGRAFT_REJECTION,KEGG_ALLOGRAFT_REJECTION,1/16,37/21728,0.026909898827950585,0.07048323500705518,0.031812511974743204,HLA-F,1
STEARMAN_TUMOR_FIELD_EFFECT_UP,STEARMAN_TUMOR_FIELD_EFFECT_UP,1/16,37/21728,0.026909898827950585,0.07048323500705518,0.031812511974743204,PTGS1,1
BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN,BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN,1/16,38/21728,0.02762768231505308,0.07181088418530973,0.03241174462031137,PLSCR1,1
REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE,REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE,1/16,38/21728,0.02762768231505308,0.07181088418530973,0.03241174462031137,FGF20,1
WANG_LMO4_TARGETS_DN,WANG_LMO4_TARGETS_DN,2/16,361/21728,0.02832857446847035,0.07229559613486157,0.03263051869754939,BST2/IFITM3,2
CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP,CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP,1/16,39/21728,0.028344969409703435,0.07229559613486157,0.03263051869754939,HP,1
GEISS_RESPONSE_TO_DSRNA_UP,GEISS_RESPONSE_TO_DSRNA_UP,1/16,39/21728,0.028344969409703435,0.07229559613486157,0.03263051869754939,IRF1,1
NEWMAN_ERCC6_TARGETS_DN,NEWMAN_ERCC6_TARGETS_DN,1/16,39/21728,0.028344969409703435,0.07229559613486157,0.03263051869754939,PTGS1,1
SESTO_RESPONSE_TO_UV_C6,SESTO_RESPONSE_TO_UV_C6,1/16,39/21728,0.028344969409703435,0.07229559613486157,0.03263051869754939,PTGS1,1
BROWNE_HCMV_INFECTION_2HR_UP,BROWNE_HCMV_INFECTION_2HR_UP,1/16,40/21728,0.02906176043231601,0.07249472107841466,0.032720393469197126,IRF1,1
KRASNOSELSKAYA_ILF3_TARGETS_UP,KRASNOSELSKAYA_ILF3_TARGETS_UP,1/16,40/21728,0.02906176043231601,0.07249472107841466,0.032720393469197126,PLSCR1,1
PID_IFNG_PATHWAY,PID_IFNG_PATHWAY,1/16,40/21728,0.02906176043231601,0.07249472107841466,0.032720393469197126,IRF1,1
REACTOME_SIGNALING_BY_FGFR3,REACTOME_SIGNALING_BY_FGFR3,1/16,40/21728,0.02906176043231601,0.07249472107841466,0.032720393469197126,FGF20,1
WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,1/16,40/21728,0.02906176043231601,0.07249472107841466,0.032720393469197126,CXCL10,1
ZHAN_MULTIPLE_MYELOMA_LB_DN,ZHAN_MULTIPLE_MYELOMA_LB_DN,1/16,40/21728,0.02906176043231601,0.07249472107841466,0.032720393469197126,IRF1,1
KEGG_GRAFT_VERSUS_HOST_DISEASE,KEGG_GRAFT_VERSUS_HOST_DISEASE,1/16,41/21728,0.02977805570311487,0.07294552494180297,0.03292386317799902,HLA-F,1
LEONARD_HYPOXIA,LEONARD_HYPOXIA,1/16,41/21728,0.02977805570311487,0.07294552494180297,0.03292386317799902,DEPP1,1
LI_LUNG_CANCER,LI_LUNG_CANCER,1/16,41/21728,0.02977805570311487,0.07294552494180297,0.03292386317799902,HP,1
MCBRYAN_PUBERTAL_BREAST_3_4WK_DN,MCBRYAN_PUBERTAL_BREAST_3_4WK_DN,1/16,41/21728,0.02977805570311487,0.07294552494180297,0.03292386317799902,HP,1
REACTOME_SIGNALING_BY_FGFR4,REACTOME_SIGNALING_BY_FGFR4,1/16,41/21728,0.02977805570311487,0.07294552494180297,0.03292386317799902,FGF20,1
BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN,BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN,1/16,42/21728,0.030493855542131243,0.07443123879638486,0.03359443809961262,IFITM3,1
ABBUD_LIF_SIGNALING_1_UP,ABBUD_LIF_SIGNALING_1_UP,1/16,43/21728,0.03120916026920495,0.07457346716957393,0.03365863268183877,IRF1,1
HAHTOLA_SEZARY_SYNDROM_DN,HAHTOLA_SEZARY_SYNDROM_DN,1/16,43/21728,0.03120916026920495,0.07457346716957393,0.03365863268183877,BST2,1
KEGG_TYPE_I_DIABETES_MELLITUS,KEGG_TYPE_I_DIABETES_MELLITUS,1/16,43/21728,0.03120916026920495,0.07457346716957393,0.03365863268183877,HLA-F,1
PID_CXCR3_PATHWAY,PID_CXCR3_PATHWAY,1/16,43/21728,0.03120916026920495,0.07457346716957393,0.03365863268183877,CXCL10,1
REACTOME_SIGNALING_BY_FGFR2_IN_DISEASE,REACTOME_SIGNALING_BY_FGFR2_IN_DISEASE,1/16,43/21728,0.03120916026920495,0.07457346716957393,0.03365863268183877,FGF20,1
WP_IL6_SIGNALING_PATHWAY,WP_IL6_SIGNALING_PATHWAY,1/16,43/21728,0.03120916026920495,0.07457346716957393,0.03365863268183877,IRF1,1
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP,FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP,2/16,383/21728,0.03159395537378385,0.07489471534569045,0.033803627607916546,ISG20/IRF1,2
WANG_SMARCE1_TARGETS_DN,WANG_SMARCE1_TARGETS_DN,2/16,385/21728,0.031898013347249767,0.07489471534569045,0.033803627607916546,BST2/TNFRSF11B,2
KAAB_FAILED_HEART_VENTRICLE_DN,KAAB_FAILED_HEART_VENTRICLE_DN,1/16,44/21728,0.03192397020398452,0.07489471534569045,0.033803627607916546,IFITM3,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP,1/16,44/21728,0.03192397020398452,0.07489471534569045,0.033803627607916546,CH25H,1
WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING_PATHWAY,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING_PATHWAY,1/16,44/21728,0.03192397020398452,0.07489471534569045,0.033803627607916546,CXCL10,1
CHIBA_RESPONSE_TO_TSA,CHIBA_RESPONSE_TO_TSA,1/16,45/21728,0.0326382856659263,0.07489471534569045,0.033803627607916546,IFITM3,1
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS,KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS,1/16,45/21728,0.0326382856659263,0.07489471534569045,0.033803627607916546,CXCL10,1
REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM,REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM,1/16,45/21728,0.0326382856659263,0.07489471534569045,0.033803627607916546,CH25H,1
SAGIV_CD24_TARGETS_DN,SAGIV_CD24_TARGETS_DN,1/16,45/21728,0.0326382856659263,0.07489471534569045,0.033803627607916546,ISG20,1
WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,1/16,45/21728,0.0326382856659263,0.07489471534569045,0.033803627607916546,PTGS1,1
ZHAN_V2_LATE_DIFFERENTIATION_GENES,ZHAN_V2_LATE_DIFFERENTIATION_GENES,1/16,45/21728,0.0326382856659263,0.07489471534569045,0.033803627607916546,IRF1,1
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,2/16,390/21728,0.032663334005389226,0.07489471534569045,0.033803627607916546,TNFRSF11B/PTGS1,2
NUTT_GBM_VS_AO_GLIOMA_UP,NUTT_GBM_VS_AO_GLIOMA_UP,1/16,46/21728,0.03335210697429403,0.07545775697506389,0.03405775567929308,HLA-F,1
REACTOME_INTERLEUKIN_10_SIGNALING,REACTOME_INTERLEUKIN_10_SIGNALING,1/16,46/21728,0.03335210697429403,0.07545775697506389,0.03405775567929308,CXCL10,1
SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER,SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER,1/16,46/21728,0.03335210697429403,0.07545775697506389,0.03405775567929308,BST2,1
WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,1/16,46/21728,0.03335210697429403,0.07545775697506389,0.03405775567929308,CH25H,1
HSIAO_HOUSEKEEPING_GENES,HSIAO_HOUSEKEEPING_GENES,2/16,399/21728,0.03405939020176097,0.07556534481823685,0.034106315305549355,IFITM3/ISG20,2
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,2/16,399/21728,0.03405939020176097,0.07556534481823685,0.034106315305549355,SP100/ISG20,2
AMIT_EGF_RESPONSE_60_HELA,AMIT_EGF_RESPONSE_60_HELA,1/16,47/21728,0.03406543444816257,0.07556534481823685,0.034106315305549355,PLSCR1,1
DELACROIX_RAR_TARGETS_UP,DELACROIX_RAR_TARGETS_UP,1/16,47/21728,0.03406543444816257,0.07556534481823685,0.034106315305549355,TNFRSF11B,1
KUNINGER_IGF1_VS_PDGFB_TARGETS_DN,KUNINGER_IGF1_VS_PDGFB_TARGETS_DN,1/16,47/21728,0.03406543444816257,0.07556534481823685,0.034106315305549355,PTGS1,1
PID_IL6_7_PATHWAY,PID_IL6_7_PATHWAY,1/16,47/21728,0.03406543444816257,0.07556534481823685,0.034106315305549355,IRF1,1
BERENJENO_TRANSFORMED_BY_RHOA_DN,BERENJENO_TRANSFORMED_BY_RHOA_DN,2/16,400/21728,0.0342159627634596,0.07565282675946748,0.0341458001603903,IFITM3/TNFRSF11B,2
EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION,EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION,1/16,48/21728,0.03477826840641274,0.07591025892553549,0.03426199181738367,CXCL10,1
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP,FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP,1/16,48/21728,0.03477826840641274,0.07591025892553549,0.03426199181738367,HLA-F,1
REACTOME_IRS_MEDIATED_SIGNALLING,REACTOME_IRS_MEDIATED_SIGNALLING,1/16,48/21728,0.03477826840641274,0.07591025892553549,0.03426199181738367,FGF20,1
WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,1/16,48/21728,0.03477826840641274,0.07591025892553549,0.03426199181738367,CH25H,1
NADLER_OBESITY_DN,NADLER_OBESITY_DN,1/16,49/21728,0.03549060916773661,0.0765600472611991,0.03455527289631368,HP,1
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN,PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN,1/16,49/21728,0.03549060916773661,0.0765600472611991,0.03455527289631368,TAPBPL,1
RASHI_RESPONSE_TO_IONIZING_RADIATION_4,RASHI_RESPONSE_TO_IONIZING_RADIATION_4,1/16,49/21728,0.03549060916773661,0.0765600472611991,0.03455527289631368,SP100,1
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,2/16,409/21728,0.03563808367371529,0.0765600472611991,0.03455527289631368,BST2/IRF1,2
ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,2/16,409/21728,0.03563808367371529,0.0765600472611991,0.03455527289631368,CXCL10/CH25H,2
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,2/16,412/21728,0.03611727599947269,0.07680334346255802,0.034665084304918374,CXCL10/PLSCR1,2
LIU_SMARCA4_TARGETS,LIU_SMARCA4_TARGETS,1/16,50/21728,0.036202457050633075,0.07680334346255802,0.034665084304918374,BST2,1
REACTOME_SIGNALING_BY_FGFR1,REACTOME_SIGNALING_BY_FGFR1,1/16,50/21728,0.036202457050633075,0.07680334346255802,0.034665084304918374,FGF20,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8,1/16,50/21728,0.036202457050633075,0.07680334346255802,0.034665084304918374,PTGS1,1
APPIERTO_RESPONSE_TO_FENRETINIDE_DN,APPIERTO_RESPONSE_TO_FENRETINIDE_DN,1/16,51/21728,0.036913812373411625,0.07782757345601646,0.03512736911532082,IFITM3,1
BURTON_ADIPOGENESIS_11,BURTON_ADIPOGENESIS_11,1/16,51/21728,0.036913812373411625,0.07782757345601646,0.03512736911532082,IRF1,1
KEGG_AUTOIMMUNE_THYROID_DISEASE,KEGG_AUTOIMMUNE_THYROID_DISEASE,1/16,52/21728,0.03762467545418968,0.07883816610554822,0.035583498729144576,HLA-F,1
WANG_BARRETTS_ESOPHAGUS_UP,WANG_BARRETTS_ESOPHAGUS_UP,1/16,52/21728,0.03762467545418968,0.07883816610554822,0.035583498729144576,ISG20,1
SWEET_LUNG_CANCER_KRAS_DN,SWEET_LUNG_CANCER_KRAS_DN,2/16,423/21728,0.037896089468835166,0.07916330346097163,0.035730249030997314,HP/IFITM3,2
HAN_SATB1_TARGETS_UP,HAN_SATB1_TARGETS_UP,2/16,425/21728,0.03822315553799769,0.07960235144151813,0.03592841273811469,BST2/ISG20,2
BORLAK_LIVER_CANCER_EGF_UP,BORLAK_LIVER_CANCER_EGF_UP,1/16,54/21728,0.03904492616126187,0.07985017757963678,0.036040268727496626,PLSCR1,1
REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE,REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE,1/16,54/21728,0.03904492616126187,0.07985017757963678,0.036040268727496626,FGF20,1
REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R,REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R,1/16,54/21728,0.03904492616126187,0.07985017757963678,0.036040268727496626,FGF20,1
SESTO_RESPONSE_TO_UV_C2,SESTO_RESPONSE_TO_UV_C2,1/16,54/21728,0.03904492616126187,0.07985017757963678,0.036040268727496626,PLSCR1,1
WIERENGA_STAT5A_TARGETS_GROUP2,WIERENGA_STAT5A_TARGETS_GROUP2,1/16,54/21728,0.03904492616126187,0.07985017757963678,0.036040268727496626,CXCL10,1
THUM_SYSTOLIC_HEART_FAILURE_UP,THUM_SYSTOLIC_HEART_FAILURE_UP,2/16,430/21728,0.039045681547751905,0.07985017757963678,0.036040268727496626,DEPP1/TNFRSF11B,2
BOCHKIS_FOXA2_TARGETS,BOCHKIS_FOXA2_TARGETS,2/16,433/21728,0.039542512680479654,0.07986043693791696,0.036044899274861666,DEPP1/TMEM140,2
JOHNSTONE_PARVB_TARGETS_3_UP,JOHNSTONE_PARVB_TARGETS_3_UP,2/16,433/21728,0.039542512680479654,0.07986043693791696,0.036044899274861666,HLA-F/IFITM3,2
ODONNELL_TFRC_TARGETS_UP,ODONNELL_TFRC_TARGETS_UP,2/16,434/21728,0.03970867301014196,0.07986043693791696,0.036044899274861666,DEPP1/PTGS1,2
KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY,KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY,1/16,55/21728,0.03975431442283972,0.07986043693791696,0.036044899274861666,CXCL10,1
MIKKELSEN_IPS_ICP_WITH_H3K27ME3,MIKKELSEN_IPS_ICP_WITH_H3K27ME3,1/16,55/21728,0.03975431442283972,0.07986043693791696,0.036044899274861666,CXCL10,1
WP_RANKLRANK_SIGNALING_PATHWAY,WP_RANKLRANK_SIGNALING_PATHWAY,1/16,55/21728,0.03975431442283972,0.07986043693791696,0.036044899274861666,TNFRSF11B,1
LEE_LIVER_CANCER_MYC_E2F1_UP,LEE_LIVER_CANCER_MYC_E2F1_UP,1/16,56/21728,0.04046321171298073,0.08057148297233882,0.036365828932565014,PLSCR1,1
MAYBURD_RESPONSE_TO_L663536_DN,MAYBURD_RESPONSE_TO_L663536_DN,1/16,56/21728,0.04046321171298073,0.08057148297233882,0.036365828932565014,PLSCR1,1
REACTOME_REGULATED_NECROSIS,REACTOME_REGULATED_NECROSIS,1/16,56/21728,0.04046321171298073,0.08057148297233882,0.036365828932565014,IRF1,1
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN,1/16,57/21728,0.04117161834885141,0.08123731201753129,0.03666634996385986,HP,1
NAGASHIMA_EGF_SIGNALING_UP,NAGASHIMA_EGF_SIGNALING_UP,1/16,57/21728,0.04117161834885141,0.08123731201753129,0.03666634996385986,TNFRSF11B,1
WP_MALIGNANT_PLEURAL_MESOTHELIOMA,WP_MALIGNANT_PLEURAL_MESOTHELIOMA,2/16,446/21728,0.0417238632813523,0.08123731201753129,0.03666634996385986,FGF20/CXCL10,2
HUPER_BREAST_BASAL_VS_LUMINAL_DN,HUPER_BREAST_BASAL_VS_LUMINAL_DN,1/16,58/21728,0.041879534647426664,0.08123731201753129,0.03666634996385986,HLA-F,1
KEGG_ARACHIDONIC_ACID_METABOLISM,KEGG_ARACHIDONIC_ACID_METABOLISM,1/16,58/21728,0.041879534647426664,0.08123731201753129,0.03666634996385986,PTGS1,1
LEE_EARLY_T_LYMPHOCYTE_DN,LEE_EARLY_T_LYMPHOCYTE_DN,1/16,58/21728,0.041879534647426664,0.08123731201753129,0.03666634996385986,HLA-F,1
LIANG_SILENCED_BY_METHYLATION_2,LIANG_SILENCED_BY_METHYLATION_2,1/16,58/21728,0.041879534647426664,0.08123731201753129,0.03666634996385986,SP100,1
PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP,PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP,1/16,58/21728,0.041879534647426664,0.08123731201753129,0.03666634996385986,PLSCR1,1
REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES,REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES,1/16,58/21728,0.041879534647426664,0.08123731201753129,0.03666634996385986,CXCL10,1
BARIS_THYROID_CANCER_DN,BARIS_THYROID_CANCER_DN,1/16,59/21728,0.04258696092548997,0.08123731201753129,0.03666634996385986,IRF1,1
CORRE_MULTIPLE_MYELOMA_DN,CORRE_MULTIPLE_MYELOMA_DN,1/16,59/21728,0.04258696092548997,0.08123731201753129,0.03666634996385986,CH25H,1
GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP,GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP,1/16,59/21728,0.04258696092548997,0.08123731201753129,0.03666634996385986,CXCL10,1
ONDER_CDH1_TARGETS_3_DN,ONDER_CDH1_TARGETS_3_DN,1/16,59/21728,0.04258696092548997,0.08123731201753129,0.03666634996385986,DEPP1,1
REACTOME_ARACHIDONIC_ACID_METABOLISM,REACTOME_ARACHIDONIC_ACID_METABOLISM,1/16,59/21728,0.04258696092548997,0.08123731201753129,0.03666634996385986,PTGS1,1
ZHENG_IL22_SIGNALING_UP,ZHENG_IL22_SIGNALING_UP,1/16,59/21728,0.04258696092548997,0.08123731201753129,0.03666634996385986,HP,1
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,2/16,453/21728,0.04291732915217538,0.08163883003528334,0.03684757457346431,TAPBPL/PLSCR1,2
WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,1/16,60/21728,0.04329389749963708,0.08209379378452415,0.037052921841071264,TNFRSF11B,1
MARTENS_BOUND_BY_PML_RARA_FUSION,MARTENS_BOUND_BY_PML_RARA_FUSION,2/16,456/21728,0.04343281319625138,0.08209379378452415,0.037052921841071264,IFITM3/IRF1,2
MEBARKI_HCC_PROGENITOR_FZD8CRD_DN,MEBARKI_HCC_PROGENITOR_FZD8CRD_DN,2/16,459/21728,0.043950679689118595,0.08209379378452415,0.037052921841071264,HP/SP100,2
DASU_IL6_SIGNALING_UP,DASU_IL6_SIGNALING_UP,1/16,61/21728,0.04400034468627212,0.08209379378452415,0.037052921841071264,HLA-F,1
LEE_LIVER_CANCER_MYC_TGFA_UP,LEE_LIVER_CANCER_MYC_TGFA_UP,1/16,61/21728,0.04400034468627212,0.08209379378452415,0.037052921841071264,PLSCR1,1
LINDSTEDT_DENDRITIC_CELL_MATURATION_A,LINDSTEDT_DENDRITIC_CELL_MATURATION_A,1/16,61/21728,0.04400034468627212,0.08209379378452415,0.037052921841071264,CXCL10,1
WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_RLR_PATHWAY,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_RLR_PATHWAY,1/16,61/21728,0.04400034468627212,0.08209379378452415,0.037052921841071264,CXCL10,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN,1/16,62/21728,0.0447063028016097,0.08318303881938853,0.03754455110172572,CH25H,1
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,1/16,63/21728,0.04541177216167491,0.08358220768135302,0.03772471542306992,BST2,1
PHONG_TNF_TARGETS_UP,PHONG_TNF_TARGETS_UP,1/16,63/21728,0.04541177216167491,0.08358220768135302,0.03772471542306992,IRF1,1
REACTOME_SIGNALING_BY_FGFR_IN_DISEASE,REACTOME_SIGNALING_BY_FGFR_IN_DISEASE,1/16,63/21728,0.04541177216167491,0.08358220768135302,0.03772471542306992,FGF20,1
WP_MIRNAS_INVOLVEMENT_IN_THE_IMMUNE_RESPONSE_IN_SEPSIS,WP_MIRNAS_INVOLVEMENT_IN_THE_IMMUNE_RESPONSE_IN_SEPSIS,1/16,63/21728,0.04541177216167491,0.08358220768135302,0.03772471542306992,IRF1,1
BILBAN_B_CLL_LPL_UP,BILBAN_B_CLL_LPL_UP,1/16,64/21728,0.04611675308230323,0.08390860116761757,0.037872032677864334,TMEM140,1
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP,GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP,1/16,64/21728,0.04611675308230323,0.08390860116761757,0.037872032677864334,CXCL10,1
WP_PROTEASOME_DEGRADATION,WP_PROTEASOME_DEGRADATION,1/16,64/21728,0.04611675308230323,0.08390860116761757,0.037872032677864334,HLA-F,1
ONDER_CDH1_TARGETS_2_DN,ONDER_CDH1_TARGETS_2_DN,2/16,473/21728,0.0463985526870243,0.08390860116761757,0.037872032677864334,DEPP1/ISG20,2
AMIT_SERUM_RESPONSE_120_MCF10A,AMIT_SERUM_RESPONSE_120_MCF10A,1/16,65/21728,0.046821245879140494,0.08390860116761757,0.037872032677864334,CXCL10,1
BROWNE_HCMV_INFECTION_6HR_UP,BROWNE_HCMV_INFECTION_6HR_UP,1/16,65/21728,0.046821245879140494,0.08390860116761757,0.037872032677864334,CH25H,1
GUO_HEX_TARGETS_DN,GUO_HEX_TARGETS_DN,1/16,65/21728,0.046821245879140494,0.08390860116761757,0.037872032677864334,IFITM3,1
LEE_LIVER_CANCER_ACOX1_UP,LEE_LIVER_CANCER_ACOX1_UP,1/16,65/21728,0.046821245879140494,0.08390860116761757,0.037872032677864334,PLSCR1,1
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL,1/16,65/21728,0.046821245879140494,0.08390860116761757,0.037872032677864334,ISG20,1
WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP,WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP,1/16,65/21728,0.046821245879140494,0.08390860116761757,0.037872032677864334,BST2,1
REACTOME_NEUTROPHIL_DEGRANULATION,REACTOME_NEUTROPHIL_DEGRANULATION,2/16,479/21728,0.04746315832629811,0.08483572393755646,0.038290488275394524,HP/BST2,2
ENK_UV_RESPONSE_KERATINOCYTE_DN,ENK_UV_RESPONSE_KERATINOCYTE_DN,2/16,481/21728,0.047820071106838155,0.08524991733967745,0.03847743390244349,SP100/PLSCR1,2
SWEET_LUNG_CANCER_KRAS_UP,SWEET_LUNG_CANCER_KRAS_UP,2/16,482/21728,0.04799890890494282,0.08530854871495212,0.03850389709369506,PTGS1/CH25H,2
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP,2/16,483/21728,0.048178000417470224,0.08530854871495212,0.03850389709369506,HLA-F/IRF1,2
PID_TELOMERASE_PATHWAY,PID_TELOMERASE_PATHWAY,1/16,67/21728,0.048228768363078656,0.08530854871495212,0.03850389709369506,IRF1,1
MATSUDA_NATURAL_KILLER_DIFFERENTIATION,MATSUDA_NATURAL_KILLER_DIFFERENTIATION,2/16,485/21728,0.04853694291584667,0.08563123866759477,0.03864954276364121,CXCL10/PLSCR1,2
LINDVALL_IMMORTALIZED_BY_TERT_UP,LINDVALL_IMMORTALIZED_BY_TERT_UP,1/16,68/21728,0.04893179868052422,0.08588287345731184,0.03876311778272673,PTGS1,1
WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,1/16,68/21728,0.04893179868052422,0.08588287345731184,0.03876311778272673,CXCL10,1
REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA,REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA,1/16,69/21728,0.04963434213486939,0.08689199741348601,0.039218584503806955,HP,1
KEGG_VIRAL_MYOCARDITIS,KEGG_VIRAL_MYOCARDITIS,1/16,70/21728,0.05033639904081333,0.0874466524152905,0.03946892728227039,HLA-F,1
ROSS_AML_OF_FAB_M7_TYPE,ROSS_AML_OF_FAB_M7_TYPE,1/16,70/21728,0.05033639904081333,0.0874466524152905,0.03946892728227039,PTGS1,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1,1/16,70/21728,0.05033639904081333,0.0874466524152905,0.03946892728227039,HP,1
BASSO_CD40_SIGNALING_DN,BASSO_CD40_SIGNALING_DN,1/16,71/21728,0.05103796971286756,0.08754875912962924,0.03951501300850412,ISG20,1
KEGG_MELANOMA,KEGG_MELANOMA,1/16,71/21728,0.05103796971286756,0.08754875912962924,0.03951501300850412,FGF20,1
KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY,KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY,1/16,71/21728,0.05103796971286756,0.08754875912962924,0.03951501300850412,CXCL10,1
MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP,MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP,1/16,71/21728,0.05103796971286756,0.08754875912962924,0.03951501300850412,IFITM3,1
PEART_HDAC_PROLIFERATION_CLUSTER_DN,PEART_HDAC_PROLIFERATION_CLUSTER_DN,1/16,71/21728,0.05103796971286756,0.08754875912962924,0.03951501300850412,BST2,1
RODWELL_AGING_KIDNEY_UP,RODWELL_AGING_KIDNEY_UP,2/16,500/21728,0.05126097137422239,0.08771035554232524,0.03958794932894192,HLA-F/TNFRSF11B,2
CROMER_METASTASIS_UP,CROMER_METASTASIS_UP,1/16,72/21728,0.05173905446535376,0.08830650649349853,0.039857021247548606,DEPP1,1
HOSHIDA_LIVER_CANCER_SURVIVAL_UP,HOSHIDA_LIVER_CANCER_SURVIVAL_UP,1/16,73/21728,0.052439653612405435,0.0888343385822092,0.04009525754077609,SP100,1
REACTOME_SIGNALING_BY_FGFR2,REACTOME_SIGNALING_BY_FGFR2,1/16,73/21728,0.052439653612405435,0.0888343385822092,0.04009525754077609,FGF20,1
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN,WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN,1/16,73/21728,0.052439653612405435,0.0888343385822092,0.04009525754077609,PTGS1,1
WP_CYTOSOLIC_DNASENSING_PATHWAY,WP_CYTOSOLIC_DNASENSING_PATHWAY,1/16,74/21728,0.05313976746796745,0.08979697678830231,0.040529742981968125,CXCL10,1
ANDERSEN_LIVER_CANCER_KRT19_DN,ANDERSEN_LIVER_CANCER_KRT19_DN,1/16,75/21728,0.05383939634579704,0.09030696776228518,0.04075992671240015,TMEM140,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP,1/16,75/21728,0.05383939634579704,0.09030696776228518,0.04075992671240015,HLA-F,1
PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2,PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2,1/16,75/21728,0.05383939634579704,0.09030696776228518,0.04075992671240015,ISG20,1
RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP,RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP,1/16,76/21728,0.054538540559460724,0.09091167356714143,0.041032859852547024,CH25H,1
WP_PROLACTIN_SIGNALING_PATHWAY,WP_PROLACTIN_SIGNALING_PATHWAY,1/16,76/21728,0.054538540559460724,0.09091167356714143,0.041032859852547024,IRF1,1
LEE_AGING_NEOCORTEX_UP,LEE_AGING_NEOCORTEX_UP,1/16,77/21728,0.055237200422339816,0.09091167356714143,0.041032859852547024,PTGS1,1
MAHAJAN_RESPONSE_TO_IL1A_UP,MAHAJAN_RESPONSE_TO_IL1A_UP,1/16,77/21728,0.055237200422339816,0.09091167356714143,0.041032859852547024,ISG20,1
MUNSHI_MULTIPLE_MYELOMA_UP,MUNSHI_MULTIPLE_MYELOMA_UP,1/16,77/21728,0.055237200422339816,0.09091167356714143,0.041032859852547024,ISG20,1
REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,1/16,77/21728,0.055237200422339816,0.09091167356714143,0.041032859852547024,SP100,1
RODRIGUES_THYROID_CARCINOMA_DN,RODRIGUES_THYROID_CARCINOMA_DN,1/16,77/21728,0.055237200422339816,0.09091167356714143,0.041032859852547024,IRF1,1
BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE,BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE,1/16,78/21728,0.05593537624762446,0.09091167356714143,0.041032859852547024,IFITM3,1
CHEBOTAEV_GR_TARGETS_UP,CHEBOTAEV_GR_TARGETS_UP,1/16,78/21728,0.05593537624762446,0.09091167356714143,0.041032859852547024,TMEM140,1
REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,1/16,78/21728,0.05593537624762446,0.09091167356714143,0.041032859852547024,FGF20,1
REACTOME_SIGNALING_BY_INSULIN_RECEPTOR,REACTOME_SIGNALING_BY_INSULIN_RECEPTOR,1/16,78/21728,0.05593537624762446,0.09091167356714143,0.041032859852547024,FGF20,1
ROSS_AML_WITH_AML1_ETO_FUSION,ROSS_AML_WITH_AML1_ETO_FUSION,1/16,78/21728,0.05593537624762446,0.09091167356714143,0.041032859852547024,ISG20,1
SEKI_INFLAMMATORY_RESPONSE_LPS_UP,SEKI_INFLAMMATORY_RESPONSE_LPS_UP,1/16,78/21728,0.05593537624762446,0.09091167356714143,0.041032859852547024,CXCL10,1
BILANGES_SERUM_SENSITIVE_GENES,BILANGES_SERUM_SENSITIVE_GENES,1/16,81/21728,0.05802700262701177,0.09364073172747635,0.04226461653052492,TAPBPL,1
HINATA_NFKB_TARGETS_FIBROBLAST_UP,HINATA_NFKB_TARGETS_FIBROBLAST_UP,1/16,81/21728,0.05802700262701177,0.09364073172747635,0.04226461653052492,IRF1,1
ZAMORA_NOS2_TARGETS_DN,ZAMORA_NOS2_TARGETS_DN,1/16,81/21728,0.05802700262701177,0.09364073172747635,0.04226461653052492,HP,1
ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP,ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP,1/16,82/21728,0.05872324543007745,0.09365463732525234,0.042270892803112574,PTGS1,1
PID_REG_GR_PATHWAY,PID_REG_GR_PATHWAY,1/16,82/21728,0.05872324543007745,0.09365463732525234,0.042270892803112574,IRF1,1
RADMACHER_AML_PROGNOSIS,RADMACHER_AML_PROGNOSIS,1/16,82/21728,0.05872324543007745,0.09365463732525234,0.042270892803112574,ISG20,1
ROSS_ACUTE_MYELOID_LEUKEMIA_CBF,ROSS_ACUTE_MYELOID_LEUKEMIA_CBF,1/16,82/21728,0.05872324543007745,0.09365463732525234,0.042270892803112574,ISG20,1
ZHU_CMV_24_HR_UP,ZHU_CMV_24_HR_UP,1/16,82/21728,0.05872324543007745,0.09365463732525234,0.042270892803112574,IRF1,1
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP,LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP,1/16,83/21728,0.05941900575868864,0.0945428572936144,0.04267178967421811,TNFRSF11B,1
GHANDHI_BYSTANDER_IRRADIATION_UP,GHANDHI_BYSTANDER_IRRADIATION_UP,1/16,84/21728,0.06011428392491014,0.0952042496578228,0.04297030821560285,CXCL10,1
JACKSON_DNMT1_TARGETS_UP,JACKSON_DNMT1_TARGETS_UP,1/16,84/21728,0.06011428392491014,0.0952042496578228,0.04297030821560285,CXCL10,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN,DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN,1/16,85/21728,0.06080908024061926,0.09541701300428967,0.043066338661801665,SP100,1
HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN,HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN,1/16,85/21728,0.06080908024061926,0.09541701300428967,0.043066338661801665,PLSCR1,1
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN,1/16,85/21728,0.06080908024061926,0.09541701300428967,0.043066338661801665,BST2,1
SASSON_RESPONSE_TO_FORSKOLIN_DN,SASSON_RESPONSE_TO_FORSKOLIN_DN,1/16,85/21728,0.06080908024061926,0.09541701300428967,0.043066338661801665,TNFRSF11B,1
HILLION_HMGA1B_TARGETS,HILLION_HMGA1B_TARGETS,1/16,86/21728,0.06150339501750568,0.09584396340256605,0.04325904214166364,CXCL10,1
SASSON_RESPONSE_TO_GONADOTROPHINS_DN,SASSON_RESPONSE_TO_GONADOTROPHINS_DN,1/16,86/21728,0.06150339501750568,0.09584396340256605,0.04325904214166364,TNFRSF11B,1
WP_APOPTOSIS,WP_APOPTOSIS,1/16,86/21728,0.06150339501750568,0.09584396340256605,0.04325904214166364,IRF1,1
HUMMERICH_SKIN_CANCER_PROGRESSION_UP,HUMMERICH_SKIN_CANCER_PROGRESSION_UP,1/16,87/21728,0.062197228567072105,0.09648362791384077,0.04354775384626557,IFITM3,1
REACTOME_SIGNALING_BY_FGFR,REACTOME_SIGNALING_BY_FGFR,1/16,87/21728,0.062197228567072105,0.09648362791384077,0.04354775384626557,FGF20,1
HOEBEKE_LYMPHOID_STEM_CELL_DN,HOEBEKE_LYMPHOID_STEM_CELL_DN,1/16,88/21728,0.06289058120063484,0.0966782975115854,0.043635617703660146,BST2,1
JIANG_VHL_TARGETS,JIANG_VHL_TARGETS,1/16,88/21728,0.06289058120063484,0.0966782975115854,0.043635617703660146,IRF1,1
KANG_IMMORTALIZED_BY_TERT_UP,KANG_IMMORTALIZED_BY_TERT_UP,1/16,88/21728,0.06289058120063484,0.0966782975115854,0.043635617703660146,TNFRSF11B,1
KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION,KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION,1/16,88/21728,0.06289058120063484,0.0966782975115854,0.043635617703660146,HLA-F,1
LIU_VAV3_PROSTATE_CARCINOGENESIS_UP,LIU_VAV3_PROSTATE_CARCINOGENESIS_UP,1/16,89/21728,0.06358345322932157,0.09730411606554605,0.04391808005431556,IRF1,1
WP_ALLOGRAFT_REJECTION,WP_ALLOGRAFT_REJECTION,1/16,89/21728,0.06358345322932157,0.09730411606554605,0.04391808005431556,HLA-F,1
WP_SELENIUM_MICRONUTRIENT_NETWORK,WP_SELENIUM_MICRONUTRIENT_NETWORK,1/16,91/21728,0.0649677567156498,0.09919964646492717,0.04477362511439637,PTGS1,1
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C,1/16,92/21728,0.06565918879461441,0.09958554024305659,0.04494779774476007,PTGS1,1
ELVIDGE_HIF1A_TARGETS_DN,ELVIDGE_HIF1A_TARGETS_DN,1/16,92/21728,0.06565918879461441,0.09958554024305659,0.04494779774476007,ISG20,1
GAVIN_FOXP3_TARGETS_CLUSTER_P7,GAVIN_FOXP3_TARGETS_CLUSTER_P7,1/16,92/21728,0.06565918879461441,0.09958554024305659,0.04494779774476007,IFITM3,1
DE_YY1_TARGETS_DN,DE_YY1_TARGETS_DN,1/16,93/21728,0.06635014151134944,0.10040988082050882,0.045319862739915874,TNFRSF11B,1
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN,GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN,1/16,94/21728,0.06704061517605098,0.1012298424276956,0.0456899512928157,CH25H,1
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN,CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN,1/16,97/21728,0.06910916495710862,0.10389258573022288,0.04689177685018175,DEPP1,1
GAVIN_FOXP3_TARGETS_CLUSTER_T4,GAVIN_FOXP3_TARGETS_CLUSTER_T4,1/16,97/21728,0.06910916495710862,0.10389258573022288,0.04689177685018175,PLSCR1,1
REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS,REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS,1/16,98/21728,0.06979772551190011,0.10469658826785017,0.04725466229880555,HP,1
BRUINS_UVC_RESPONSE_MIDDLE,BRUINS_UVC_RESPONSE_MIDDLE,1/16,99/21728,0.07048580856283904,0.10526499041950303,0.047511209834600644,ISG20,1
HAHTOLA_SEZARY_SYNDROM_UP,HAHTOLA_SEZARY_SYNDROM_UP,1/16,99/21728,0.07048580856283904,0.10526499041950303,0.047511209834600644,HP,1
BENPORATH_ES_CORE_NINE_CORRELATED,BENPORATH_ES_CORE_NINE_CORRELATED,1/16,100/21728,0.07117341441900404,0.10582771881952349,0.04776519653033597,IRF1,1
WINZEN_DEGRADED_VIA_KHSRP,WINZEN_DEGRADED_VIA_KHSRP,1/16,100/21728,0.07117341441900404,0.10582771881952349,0.04776519653033597,CXCL10,1
KANG_IMMORTALIZED_BY_TERT_DN,KANG_IMMORTALIZED_BY_TERT_DN,1/16,101/21728,0.07186054338928771,0.10615407819545539,0.047912498389478274,PTGS1,1
REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY,REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY,1/16,101/21728,0.07186054338928771,0.10615407819545539,0.047912498389478274,TNFRSF11B,1
SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,1/16,101/21728,0.07186054338928771,0.10615407819545539,0.047912498389478274,ISG20,1
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP,CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP,1/16,102/21728,0.07254719578239655,0.1067054866691405,0.04816137585190359,DEPP1,1
KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,1/16,102/21728,0.07254719578239655,0.1067054866691405,0.04816137585190359,CXCL10,1
BASSO_CD40_SIGNALING_UP,BASSO_CD40_SIGNALING_UP,1/16,103/21728,0.07323337190685264,0.10725145434100355,0.048407797615848264,HLA-F,1
HUMMERICH_SKIN_CANCER_PROGRESSION_DN,HUMMERICH_SKIN_CANCER_PROGRESSION_DN,1/16,103/21728,0.07323337190685264,0.10725145434100355,0.048407797615848264,HP,1
CADWELL_ATG16L1_TARGETS_UP,CADWELL_ATG16L1_TARGETS_UP,1/16,104/21728,0.0739190720709908,0.10779205156390735,0.048651795434980986,HP,1
WP_TOLLLIKE_RECEPTOR_SIGNALING_PATHWAY,WP_TOLLLIKE_RECEPTOR_SIGNALING_PATHWAY,1/16,104/21728,0.0739190720709908,0.10779205156390735,0.048651795434980986,CXCL10,1
DAZARD_RESPONSE_TO_UV_SCC_UP,DAZARD_RESPONSE_TO_UV_SCC_UP,1/16,105/21728,0.07460429658296197,0.10786735875370934,0.048685785232372096,PLSCR1,1
REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,1/16,105/21728,0.07460429658296197,0.10786735875370934,0.048685785232372096,FGF20,1
RICKMAN_HEAD_AND_NECK_CANCER_A,RICKMAN_HEAD_AND_NECK_CANCER_A,1/16,105/21728,0.07460429658296197,0.10786735875370934,0.048685785232372096,TNFRSF11B,1
STEIN_ESRRA_TARGETS_DN,STEIN_ESRRA_TARGETS_DN,1/16,105/21728,0.07460429658296197,0.10786735875370934,0.048685785232372096,TNFRSF11B,1
REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION,REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION,1/16,106/21728,0.07528904575073125,0.1083971250660634,0.04892489453480255,HLA-F,1
REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,1/16,106/21728,0.07528904575073125,0.1083971250660634,0.04892489453480255,PTGS1,1
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP,COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP,1/16,109/21728,0.07734044426570152,0.11088177377882683,0.05004633734201629,CXCL10,1
WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,1/16,109/21728,0.07734044426570152,0.11088177377882683,0.05004633734201629,PLSCR1,1
GROSS_HYPOXIA_VIA_HIF1A_DN,GROSS_HYPOXIA_VIA_HIF1A_DN,1/16,110/21728,0.07802329513261286,0.11162576467501965,0.0503821366181401,DEPP1,1
ZWANG_EGF_INTERVAL_UP,ZWANG_EGF_INTERVAL_UP,1/16,111/21728,0.07870567219237179,0.1123659596708704,0.0507162226198225,TMEM140,1
BROWNE_HCMV_INFECTION_12HR_UP,BROWNE_HCMV_INFECTION_12HR_UP,1/16,113/21728,0.08006900611767398,0.11359790242944995,0.051272258303422816,PLSCR1,1
REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1/16,113/21728,0.08006900611767398,0.11359790242944995,0.051272258303422816,FGF20,1
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN,1/16,113/21728,0.08006900611767398,0.11359790242944995,0.051272258303422816,PTGS1,1
SENESE_HDAC2_TARGETS_UP,SENESE_HDAC2_TARGETS_UP,1/16,116/21728,0.08211046111738751,0.11625202499156112,0.05247019290136153,TNFRSF11B,1
DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_DN,DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_DN,1/16,117/21728,0.08279000177175222,0.11697093611320179,0.05279467245545239,ISG20,1
WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,1/16,118/21728,0.08346907076308296,0.11768620536161388,0.05311750825502937,FGF20,1
TSENG_IRS1_TARGETS_UP,TSENG_IRS1_TARGETS_UP,1/16,119/21728,0.08414766839694643,0.11815373645014539,0.05332852777408216,CH25H,1
WP_SPINAL_CORD_INJURY,WP_SPINAL_CORD_INJURY,1/16,119/21728,0.08414766839694643,0.11815373645014539,0.05332852777408216,CXCL10,1
HOOI_ST7_TARGETS_DN,HOOI_ST7_TARGETS_DN,1/16,120/21728,0.084825794978725,0.11886083617389244,0.053647676269845575,DEPP1,1
WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP,WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP,1/16,121/21728,0.08550345081361643,0.11956437372499547,0.05396521698384524,IFITM3,1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP,1/16,123/21728,0.08685735146261586,0.12096085142339755,0.05459551528809349,PLSCR1,1
WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,1/16,123/21728,0.08685735146261586,0.12096085142339755,0.05459551528809349,CXCL10,1
MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3,MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3,1/16,126/21728,0.0888846794538748,0.12353156471038518,0.055755803223483225,PTGS1,1
SCHLOSSER_SERUM_RESPONSE_UP,SCHLOSSER_SERUM_RESPONSE_UP,1/16,127/21728,0.08955951720633937,0.12396347808438436,0.055950746735667724,IRF1,1
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP,STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP,1/16,127/21728,0.08955951720633937,0.12396347808438436,0.055950746735667724,PTGS1,1
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,1/16,128/21728,0.09023388634317142,0.12413995272666613,0.05603039832473377,HLA-F,1
MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP,MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP,1/16,128/21728,0.09023388634317142,0.12413995272666613,0.05603039832473377,IFITM3,1
WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,1/16,128/21728,0.09023388634317142,0.12413995272666613,0.05603039832473377,CXCL10,1
MIKKELSEN_MEF_LCP_WITH_H3K4ME3,MIKKELSEN_MEF_LCP_WITH_H3K4ME3,1/16,129/21728,0.090907787168102,0.1248149255271723,0.056335046377516525,TAPBPL,1
LENAOUR_DENDRITIC_CELL_MATURATION_DN,LENAOUR_DENDRITIC_CELL_MATURATION_DN,1/16,130/21728,0.09158121998468216,0.12548654086432304,0.056638179043793695,PLSCR1,1
BROWN_MYELOID_CELL_DEVELOPMENT_DN,BROWN_MYELOID_CELL_DEVELOPMENT_DN,1/16,131/21728,0.09225418509627781,0.12590200410934907,0.05682569781270567,IFITM3,1
GERY_CEBP_TARGETS,GERY_CEBP_TARGETS,1/16,131/21728,0.09225418509627781,0.12590200410934907,0.05682569781270567,HP,1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP,1/16,132/21728,0.09292668280607341,0.12631351495196805,0.05701143267018266,PLSCR1,1
POOLA_INVASIVE_BREAST_CANCER_DN,POOLA_INVASIVE_BREAST_CANCER_DN,1/16,132/21728,0.09292668280607341,0.12631351495196805,0.05701143267018266,BST2,1
ELVIDGE_HYPOXIA_BY_DMOG_UP,ELVIDGE_HYPOXIA_BY_DMOG_UP,1/16,133/21728,0.09359871341707093,0.126469690152828,0.05708192213405329,ISG20,1
KEGG_CELL_ADHESION_MOLECULES_CAMS,KEGG_CELL_ADHESION_MOLECULES_CAMS,1/16,133/21728,0.09359871341707093,0.126469690152828,0.05708192213405329,HLA-F,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN,1/16,133/21728,0.09359871341707093,0.126469690152828,0.05708192213405329,HP,1
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN,1/16,134/21728,0.09427027723208992,0.1271248689010955,0.05737763616835905,PTGS1,1
KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP,KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP,1/16,136/21728,0.09561200568455586,0.1286793989549062,0.05807927118762287,ISG20,1
MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3,MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3,1/16,137/21728,0.09628217092673108,0.129325756215195,0.058371003655362776,PTGS1,1
LIU_SOX4_TARGETS_UP,LIU_SOX4_TARGETS_UP,1/16,139/21728,0.09762110495341958,0.1308660875458243,0.05906623010028703,ISG20,1
FIGUEROA_AML_METHYLATION_CLUSTER_6_UP,FIGUEROA_AML_METHYLATION_CLUSTER_6_UP,1/16,140/21728,0.09828987434156822,0.13124589103256462,0.05923765388593998,FGF20,1
ONDER_CDH1_TARGETS_1_UP,ONDER_CDH1_TARGETS_1_UP,1/16,140/21728,0.09828987434156822,0.13124589103256462,0.05923765388593998,PTGS1,1
PROVENZANI_METASTASIS_DN,PROVENZANI_METASTASIS_DN,1/16,142/21728,0.09962601937520199,0.13276970488162929,0.05992542518809142,IFITM3,1
DARWICHE_SKIN_TUMOR_PROMOTER_UP,DARWICHE_SKIN_TUMOR_PROMOTER_UP,1/16,143/21728,0.1002933956232328,0.13287899303389406,0.05997475224653693,IFITM3,1
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,1/16,143/21728,0.1002933956232328,0.13287899303389406,0.05997475224653693,DEPP1,1
MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP,MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP,1/16,143/21728,0.1002933956232328,0.13287899303389406,0.05997475224653693,IFITM3,1
WP_ECTODERM_DIFFERENTIATION,WP_ECTODERM_DIFFERENTIATION,1/16,144/21728,0.10096030809346823,0.1335028540032075,0.06025633104403215,TNFRSF11B,1
GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB,GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB,1/16,145/21728,0.1016267570867273,0.13360583315841948,0.060302810545263916,SP100,1
MIKKELSEN_ES_LCP_WITH_H3K4ME3,MIKKELSEN_ES_LCP_WITH_H3K4ME3,1/16,145/21728,0.1016267570867273,0.13360583315841948,0.060302810545263916,TAPBPL,1
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,1/16,145/21728,0.1016267570867273,0.13360583315841948,0.060302810545263916,IFITM3,1
BASSO_B_LYMPHOCYTE_NETWORK,BASSO_B_LYMPHOCYTE_NETWORK,1/16,146/21728,0.10229274290364865,0.13396414984112448,0.06046453629122552,SP100,1
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN,VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN,1/16,146/21728,0.10229274290364865,0.13396414984112448,0.06046453629122552,ISG20,1
KAAB_FAILED_HEART_ATRIUM_DN,KAAB_FAILED_HEART_ATRIUM_DN,1/16,147/21728,0.10295826584468937,0.13457692714056327,0.06074111248944196,IFITM3,1
DARWICHE_PAPILLOMA_RISK_HIGH_UP,DARWICHE_PAPILLOMA_RISK_HIGH_UP,1/16,150/21728,0.10495206041438698,0.13613781550894768,0.06144561732531529,IFITM3,1
DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP,DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP,1/16,150/21728,0.10495206041438698,0.13613781550894768,0.06144561732531529,IFITM3,1
TSAI_RESPONSE_TO_IONIZING_RADIATION,TSAI_RESPONSE_TO_IONIZING_RADIATION,1/16,150/21728,0.10495206041438698,0.13613781550894768,0.06144561732531529,CXCL10,1
WP_REGULATION_OF_ACTIN_CYTOSKELETON,WP_REGULATION_OF_ACTIN_CYTOSKELETON,1/16,150/21728,0.10495206041438698,0.13613781550894768,0.06144561732531529,FGF20,1
REACTOME_METABOLISM_OF_STEROIDS,REACTOME_METABOLISM_OF_STEROIDS,1/16,153/21728,0.1069416999002577,0.1381922156206366,0.06237286801333318,CH25H,1
WILCOX_RESPONSE_TO_PROGESTERONE_UP,WILCOX_RESPONSE_TO_PROGESTERONE_UP,1/16,153/21728,0.1069416999002577,0.1381922156206366,0.06237286801333318,DEPP1,1
BIDUS_METASTASIS_DN,BIDUS_METASTASIS_DN,1/16,155/21728,0.10826582183650801,0.13963830430049615,0.06302555816638823,HP,1
WP_BREAST_CANCER_PATHWAY,WP_BREAST_CANCER_PATHWAY,1/16,156/21728,0.10892719238537063,0.140225742938445,0.0632906977943055,FGF20,1
BROWNE_HCMV_INFECTION_14HR_UP,BROWNE_HCMV_INFECTION_14HR_UP,1/16,157/21728,0.10958810305298772,0.14028101161482073,0.06331564323599607,HLA-F,1
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS,1/16,157/21728,0.10958810305298772,0.14028101161482073,0.06331564323599607,HP,1
NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON,NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON,1/16,157/21728,0.10958810305298772,0.14028101161482073,0.06331564323599607,TNFRSF11B,1
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP,1/16,159/21728,0.11090854593819255,0.1414395501571332,0.06383854802671442,PTGS1,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP,1/16,159/21728,0.11090854593819255,0.1414395501571332,0.06383854802671442,CH25H,1
SENGUPTA_EBNA1_ANTICORRELATED,SENGUPTA_EBNA1_ANTICORRELATED,1/16,160/21728,0.11156807875218411,0.1420146946359577,0.06409813870268127,HLA-F,1
WP_EGFEGFR_SIGNALING_PATHWAY,WP_EGFEGFR_SIGNALING_PATHWAY,1/16,163/21728,0.1135439262543696,0.14426010033437628,0.0651115995017202,PLSCR1,1
BROWNE_HCMV_INFECTION_6HR_DN,BROWNE_HCMV_INFECTION_6HR_DN,1/16,164/21728,0.11420162610041307,0.14428813984115268,0.06512425509485523,DEPP1,1
DARWICHE_PAPILLOMA_RISK_LOW_UP,DARWICHE_PAPILLOMA_RISK_LOW_UP,1/16,164/21728,0.11420162610041307,0.14428813984115268,0.06512425509485523,IFITM3,1
LIU_CMYB_TARGETS_UP,LIU_CMYB_TARGETS_UP,1/16,164/21728,0.11420162610041307,0.14428813984115268,0.06512425509485523,ISG20,1
BROWN_MYELOID_CELL_DEVELOPMENT_UP,BROWN_MYELOID_CELL_DEVELOPMENT_UP,1/16,165/21728,0.1148588684479549,0.14458205067108554,0.0652569113470237,SP100,1
WP_CHEMOKINE_SIGNALING_PATHWAY,WP_CHEMOKINE_SIGNALING_PATHWAY,1/16,165/21728,0.1148588684479549,0.14458205067108554,0.0652569113470237,CXCL10,1
KIM_WT1_TARGETS_12HR_UP,KIM_WT1_TARGETS_12HR_UP,1/16,167/21728,0.11617198183549682,0.14596516536895449,0.0658811782792097,TNFRSF11B,1
IBRAHIM_NRF2_DOWN,IBRAHIM_NRF2_DOWN,1/16,168/21728,0.11682785346903135,0.14598122607781716,0.06588842725824656,DEPP1,1
SASAKI_ADULT_T_CELL_LEUKEMIA,SASAKI_ADULT_T_CELL_LEUKEMIA,1/16,168/21728,0.11682785346903135,0.14598122607781716,0.06588842725824656,ISG20,1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,1/16,168/21728,0.11682785346903135,0.14598122607781716,0.06588842725824656,PLSCR1,1
SERVITJA_ISLET_HNF1A_TARGETS_UP,SERVITJA_ISLET_HNF1A_TARGETS_UP,1/16,169/21728,0.11748326879113224,0.14653132975597263,0.06613671580298942,IFITM3,1
REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1/16,170/21728,0.11813822809811936,0.14707885435981588,0.06638384028605958,IRF1,1
ELVIDGE_HYPOXIA_UP,ELVIDGE_HYPOXIA_UP,1/16,172/21728,0.1194467798511405,0.14843660050844282,0.06699665715815026,ISG20,1
MOHANKUMAR_HOXA1_TARGETS_DN,MOHANKUMAR_HOXA1_TARGETS_DN,1/16,173/21728,0.12010037288891995,0.14897696527751272,0.06724055005956213,HLA-F,1
BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP,BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP,1/16,174/21728,0.12075351109508015,0.149243450191923,0.067360827662171,IRF1,1
MIKKELSEN_IPS_LCP_WITH_H3K4ME3,MIKKELSEN_IPS_LCP_WITH_H3K4ME3,1/16,174/21728,0.12075351109508015,0.149243450191923,0.067360827662171,TAPBPL,1
REACTOME_FATTY_ACID_METABOLISM,REACTOME_FATTY_ACID_METABOLISM,1/16,177/21728,0.12271019967722385,0.15138703981918378,0.06832833391637942,PTGS1,1
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,1/16,179/21728,0.12401238998530673,0.152441223068581,0.06880413808799082,BST2,1
MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP,MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP,1/16,179/21728,0.12401238998530673,0.152441223068581,0.06880413808799082,IFITM3,1
FERNANDEZ_BOUND_BY_MYC,FERNANDEZ_BOUND_BY_MYC,1/16,181/21728,0.12531276804630653,0.15348560258909127,0.06927551735994228,ISG20,1
KEGG_ENDOCYTOSIS,KEGG_ENDOCYTOSIS,1/16,181/21728,0.12531276804630653,0.15348560258909127,0.06927551735994228,HLA-F,1
BROWNE_HCMV_INFECTION_18HR_DN,BROWNE_HCMV_INFECTION_18HR_DN,1/16,182/21728,0.125962278219939,0.15369397497682868,0.06936956595290823,TNFRSF11B,1
WANG_CLIM2_TARGETS_DN,WANG_CLIM2_TARGETS_DN,1/16,182/21728,0.125962278219939,0.15369397497682868,0.06936956595290823,SP100,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP,1/16,183/21728,0.1266113362143919,0.15369397497682868,0.06936956595290823,TNFRSF11B,1
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,1/16,183/21728,0.1266113362143919,0.15369397497682868,0.06936956595290823,SP100,1
WU_CELL_MIGRATION,WU_CELL_MIGRATION,1/16,183/21728,0.1266113362143919,0.15369397497682868,0.06936956595290823,BST2,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,1/16,184/21728,0.12725994232349236,0.15420644256636706,0.0696008675003929,CH25H,1
WP_VITAMIN_D_RECEPTOR_PATHWAY,WP_VITAMIN_D_RECEPTOR_PATHWAY,1/16,186/21728,0.12855580006005862,0.1554999997174066,0.07018471275598227,TNFRSF11B,1
REACTOME_SUMOYLATION,REACTOME_SUMOYLATION,1/16,187/21728,0.1292030522742933,0.15572969663503317,0.07028838614642505,SP100,1
VERHAAK_AML_WITH_NPM1_MUTATED_UP,VERHAAK_AML_WITH_NPM1_MUTATED_UP,1/16,187/21728,0.1292030522742933,0.15572969663503317,0.07028838614642505,CXCL10,1
KEGG_CHEMOKINE_SIGNALING_PATHWAY,KEGG_CHEMOKINE_SIGNALING_PATHWAY,1/16,189/21728,0.13049620486025815,0.15701045143080528,0.07086645307642808,CXCL10,1
REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1/16,191/21728,0.1317875569416116,0.15828452606214727,0.07144150492332792,HLA-F,1
BURTON_ADIPOGENESIS_6,BURTON_ADIPOGENESIS_6,1/16,193/21728,0.13307711085835383,0.15955195861714605,0.07201355887813068,HP,1
RIGGI_EWING_SARCOMA_PROGENITOR_DN,RIGGI_EWING_SARCOMA_PROGENITOR_DN,1/16,194/21728,0.13372121423547323,0.15976166121817065,0.07210820786104928,PTGS1,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP,1/16,194/21728,0.13372121423547323,0.15976166121817065,0.07210820786104928,CXCL10,1
PLASARI_TGFB1_TARGETS_10HR_UP,PLASARI_TGFB1_TARGETS_10HR_UP,1/16,195/21728,0.13436486894766042,0.1602495197081554,0.07232840212501954,TNFRSF11B,1
REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS,REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS,1/16,198/21728,0.1362931440108075,0.16226508928559424,0.07323812670437209,CXCL10,1
WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN,WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN,1/16,199/21728,0.1369350069785651,0.162744746513792,0.07345461934002206,PTGS1,1
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,1/16,200/21728,0.13757642273816095,0.16322220188969966,0.07367011817264442,CXCL10,1
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP,1/16,204/21728,0.14013761950882409,0.16597168501827686,0.07491109363217692,PLSCR1,1
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN,1/16,206/21728,0.1414155421983373,0.16719441707824254,0.0754629720795221,DEPP1,1
REACTOME_PROGRAMMED_CELL_DEATH,REACTOME_PROGRAMMED_CELL_DEATH,1/16,208/21728,0.14269168418343325,0.16841080923555987,0.0760119890204552,IRF1,1
RIZKI_TUMOR_INVASIVENESS_3D_UP,RIZKI_TUMOR_INVASIVENESS_3D_UP,1/16,209/21728,0.14332908813571354,0.16887043083117806,0.07621943860067083,BST2,1
KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,1/16,213/21728,0.14587426375682966,0.17157232058445768,0.07743893285518455,FGF20,1
VERHAAK_GLIOBLASTOMA_MESENCHYMAL,VERHAAK_GLIOBLASTOMA_MESENCHYMAL,1/16,216/21728,0.14777849135957866,0.17351233209633288,0.0783145544047132,SP100,1
KIM_WT1_TARGETS_12HR_DN,KIM_WT1_TARGETS_12HR_DN,1/16,217/21728,0.14841234893387434,0.17395664307051364,0.07851509355682817,PLSCR1,1
RIGGINS_TAMOXIFEN_RESISTANCE_DN,RIGGINS_TAMOXIFEN_RESISTANCE_DN,1/16,221/21728,0.15094336210623915,0.17661929483565098,0.07971687779891813,IFITM3,1
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,1/16,222/21728,0.15157501255522288,0.17670966313394135,0.07975766540708072,CXCL10,1
REACTOME_BIOLOGICAL_OXIDATIONS,REACTOME_BIOLOGICAL_OXIDATIONS,1/16,222/21728,0.15157501255522288,0.17670966313394135,0.07975766540708072,PTGS1,1
PEDRIOLI_MIR31_TARGETS_UP,PEDRIOLI_MIR31_TARGETS_UP,1/16,223/21728,0.15220622244079507,0.17670966313394135,0.07975766540708072,TNFRSF11B,1
RODWELL_AGING_KIDNEY_NO_BLOOD_UP,RODWELL_AGING_KIDNEY_NO_BLOOD_UP,1/16,223/21728,0.15220622244079507,0.17670966313394135,0.07975766540708072,TNFRSF11B,1
BROWNE_HCMV_INFECTION_16HR_UP,BROWNE_HCMV_INFECTION_16HR_UP,1/16,224/21728,0.1528369920497672,0.17670966313394135,0.07975766540708072,PLSCR1,1
DAZARD_RESPONSE_TO_UV_NHEK_UP,DAZARD_RESPONSE_TO_UV_NHEK_UP,1/16,224/21728,0.1528369920497672,0.17670966313394135,0.07975766540708072,HLA-F,1
VANTVEER_BREAST_CANCER_ESR1_DN,VANTVEER_BREAST_CANCER_ESR1_DN,1/16,224/21728,0.1528369920497672,0.17670966313394135,0.07975766540708072,PLSCR1,1
PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,1/16,225/21728,0.15346732166877797,0.17713770518040303,0.07995086160086204,TNFRSF11B,1
DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,1/16,228/21728,0.15535567344982548,0.17901389783304764,0.08079767859533181,ISG20,1
BENPORATH_MYC_TARGETS_WITH_EBOX,BENPORATH_MYC_TARGETS_WITH_EBOX,1/16,230/21728,0.15661237993462607,0.18015714651263576,0.08131368232736631,ISG20,1
DELYS_THYROID_CANCER_DN,DELYS_THYROID_CANCER_DN,1/16,233/21728,0.15849415332171202,0.1820143649444956,0.0821519353331675,TNFRSF11B,1
HOSHIDA_LIVER_CANCER_SUBCLASS_S1,HOSHIDA_LIVER_CANCER_SUBCLASS_S1,1/16,235/21728,0.15974648134766578,0.18252911711033623,0.08238426802104984,IRF1,1
JAATINEN_HEMATOPOIETIC_STEM_CELL_DN,JAATINEN_HEMATOPOIETIC_STEM_CELL_DN,1/16,235/21728,0.15974648134766578,0.18252911711033623,0.08238426802104984,ISG20,1
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN,1/16,235/21728,0.15974648134766578,0.18252911711033623,0.08238426802104984,TNFRSF11B,1
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,1/16,236/21728,0.16037198994574153,0.18293689305368505,0.08256831713683598,ISG20,1
LEE_RECENT_THYMIC_EMIGRANT,LEE_RECENT_THYMIC_EMIGRANT,1/16,237/21728,0.16099706198002728,0.1833428080408003,0.08275152631256462,PLSCR1,1
ZWANG_EGF_INTERVAL_DN,ZWANG_EGF_INTERVAL_DN,1/16,238/21728,0.16162169773491653,0.18374687171532245,0.08293389990087975,IRF1,1
ALFANO_MYC_TARGETS,ALFANO_MYC_TARGETS,1/16,239/21728,0.16224589749462992,0.18384268917444757,0.08297714698035194,IRF1,1
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,1/16,239/21728,0.16224589749462992,0.18384268917444757,0.08297714698035194,IFITM3,1
RUTELLA_RESPONSE_TO_HGF_DN,RUTELLA_RESPONSE_TO_HGF_DN,1/16,240/21728,0.16286966154321703,0.18424292277563253,0.08315779187029092,PLSCR1,1
CHYLA_CBFA2T3_TARGETS_DN,CHYLA_CBFA2T3_TARGETS_DN,1/16,243/21728,0.1647383422601335,0.18543274558537343,0.08369481677243842,ISG20,1
SENESE_HDAC1_AND_HDAC2_TARGETS_UP,SENESE_HDAC1_AND_HDAC2_TARGETS_UP,1/16,243/21728,0.1647383422601335,0.18543274558537343,0.08369481677243842,TNFRSF11B,1
WINTER_HYPOXIA_METAGENE,WINTER_HYPOXIA_METAGENE,1/16,243/21728,0.1647383422601335,0.18543274558537343,0.08369481677243842,PTGS1,1
BLUM_RESPONSE_TO_SALIRASIB_UP,BLUM_RESPONSE_TO_SALIRASIB_UP,1/16,245/21728,0.16598195604895227,0.18652427734213944,0.08418747814190389,ISG20,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,1/16,247/21728,0.16722383379585215,0.18761026493406147,0.08467763716012977,DEPP1,1
BILD_E2F3_ONCOGENIC_SIGNATURE,BILD_E2F3_ONCOGENIC_SIGNATURE,1/16,248/21728,0.16784412236059587,0.1879964594203385,0.08485194551470568,PTGS1,1
HSIAO_LIVER_SPECIFIC_GENES,HSIAO_LIVER_SPECIFIC_GENES,1/16,249/21728,0.1684639777629341,0.18807208009271825,0.08488607680203064,HP,1
WP_MAPK_SIGNALING_PATHWAY,WP_MAPK_SIGNALING_PATHWAY,1/16,249/21728,0.1684639777629341,0.18807208009271825,0.08488607680203064,FGF20,1
VERHAAK_AML_WITH_NPM1_MUTATED_DN,VERHAAK_AML_WITH_NPM1_MUTATED_DN,1/16,250/21728,0.1690834002852023,0.18845465727368702,0.08505875249079003,ISG20,1
DANG_REGULATED_BY_MYC_DN,DANG_REGULATED_BY_MYC_DN,1/16,251/21728,0.16970239020956357,0.18883550283123005,0.08523064661367831,CXCL10,1
JAEGER_METASTASIS_DN,JAEGER_METASTASIS_DN,1/16,259/21728,0.1746387698832017,0.1940114229860691,0.08756679111512819,PTGS1,1
AFFAR_YY1_TARGETS_DN,AFFAR_YY1_TARGETS_DN,1/16,263/21728,0.1770966291400946,0.1964215056097792,0.08865457861976278,PTGS1,1
MCLACHLAN_DENTAL_CARIES_UP,MCLACHLAN_DENTAL_CARIES_UP,1/16,265/21728,0.1783229839764603,0.19713953261034003,0.08897865912701027,DEPP1,1
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,1/16,265/21728,0.1783229839764603,0.19713953261034003,0.08897865912701027,SP100,1
KOYAMA_SEMA3B_TARGETS_UP,KOYAMA_SEMA3B_TARGETS_UP,1/16,266/21728,0.178935518676007,0.19749609111565763,0.08913959132200638,SP100,1
CAIRO_HEPATOBLASTOMA_DN,CAIRO_HEPATOBLASTOMA_DN,1/16,267/21728,0.1795476252691106,0.19753139387441732,0.08915552517401633,HP,1
KEGG_MAPK_SIGNALING_PATHWAY,KEGG_MAPK_SIGNALING_PATHWAY,1/16,267/21728,0.1795476252691106,0.19753139387441732,0.08915552517401633,FGF20,1
HOLLMANN_APOPTOSIS_VIA_CD40_DN,HOLLMANN_APOPTOSIS_VIA_CD40_DN,1/16,268/21728,0.18015930403504365,0.19788465491591084,0.0893149690632135,HLA-F,1
MEISSNER_BRAIN_HCP_WITH_H3K27ME3,MEISSNER_BRAIN_HCP_WITH_H3K27ME3,1/16,271/21728,0.18199177616002205,0.19925466168002415,0.08993331974737932,FGF20,1
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP,1/16,271/21728,0.18199177616002205,0.19925466168002415,0.08993331974737932,SP100,1
ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN,ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN,1/16,274/21728,0.18382040787808795,0.20061169513618252,0.0905458149466965,DEPP1,1
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,1/16,274/21728,0.18382040787808795,0.20061169513618252,0.0905458149466965,DEPP1,1
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN,1/16,276/21728,0.18503736584143238,0.2016167138208247,0.09099942875907074,DEPP1,1
FORTSCHEGGER_PHF8_TARGETS_UP,FORTSCHEGGER_PHF8_TARGETS_UP,1/16,278/21728,0.18625262251936991,0.20261667082378743,0.09145075798832356,TNFRSF11B,1
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,1/16,285/21728,0.1904926552967845,0.20689872130320613,0.09338345563109389,IFITM3,1
LU_EZH2_TARGETS_UP,LU_EZH2_TARGETS_UP,1/16,288/21728,0.19230346423441347,0.20853289672553435,0.0941210384787944,BST2,1
WANG_MLL_TARGETS,WANG_MLL_TARGETS,1/16,293/21728,0.19531304277368078,0.21145974901252243,0.09544206926602758,TMEM140,1
MUELLER_PLURINET,MUELLER_PLURINET,1/16,299/21728,0.19891065939972563,0.21467220134899073,0.09689200524600865,PLSCR1,1
SABATES_COLORECTAL_ADENOMA_DN,SABATES_COLORECTAL_ADENOMA_DN,1/16,299/21728,0.19891065939972563,0.21467220134899073,0.09689200524600865,TMEM140,1
REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,1/16,307/21728,0.2036840289142655,0.21947598685223862,0.09906018728008917,FGF20,1
HORIUCHI_WTAP_TARGETS_UP,HORIUCHI_WTAP_TARGETS_UP,1/16,309/21728,0.20487319789642988,0.22006095862376773,0.0993242134912129,PTGS1,1
WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING_PATHWAY,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING_PATHWAY,1/16,309/21728,0.20487319789642988,0.22006095862376773,0.0993242134912129,FGF20,1
REACTOME_G_ALPHA_I_SIGNALLING_EVENTS,REACTOME_G_ALPHA_I_SIGNALLING_EVENTS,1/16,314/21728,0.2078388407479136,0.22289488275484903,0.10060330128204023,CXCL10,1
HELLER_HDAC_TARGETS_UP,HELLER_HDAC_TARGETS_UP,1/16,317/21728,0.20961324559889394,0.2244443714667402,0.10130266089850552,CXCL10,1
HORIUCHI_WTAP_TARGETS_DN,HORIUCHI_WTAP_TARGETS_DN,1/16,318/21728,0.2102038853667897,0.22472346300594,0.1014286284840165,DEPP1,1
LEI_MYB_TARGETS,LEI_MYB_TARGETS,1/16,323/21728,0.21315088251877168,0.22751685108978606,0.10268942038521915,ISG20,1
SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,1/16,324/21728,0.2137390435035743,0.22778761913291723,0.1028116311721336,TNFRSF11B,1
KEGG_PATHWAYS_IN_CANCER,KEGG_PATHWAYS_IN_CANCER,1/16,325/21728,0.21432679230304819,0.2280571024349622,0.1029332620929113,FGF20,1
FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,1/16,327/21728,0.21550105442431156,0.228592239973452,0.10317479569093127,BST2,1
REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,1/16,327/21728,0.21550105442431156,0.228592239973452,0.10317479569093127,FGF20,1
FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,1/16,329/21728,0.21667367103752644,0.22947864693087947,0.1035748742620246,PLSCR1,1
REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1/16,331/21728,0.21784464429503947,0.23036056329956814,0.10397292601201623,CXCL10,1
WP_PI3KAKT_SIGNALING_PATHWAY,WP_PI3KAKT_SIGNALING_PATHWAY,1/16,345/21728,0.22599562338685342,0.2386093325991429,0.10769599678329041,FGF20,1
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,1/16,353/21728,0.23061750161146677,0.2431122578907258,0.10972838597123726,CH25H,1
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,1/16,357/21728,0.23291872584631257,0.2447803276255229,0.1104812669706356,DEPP1,1
YOSHIMURA_MAPK8_TARGETS_DN,YOSHIMURA_MAPK8_TARGETS_DN,1/16,357/21728,0.23291872584631257,0.2447803276255229,0.1104812669706356,PTGS1,1
SANSOM_APC_TARGETS_DN,SANSOM_APC_TARGETS_DN,1/16,361/21728,0.2352134960944703,0.24681107987724848,0.1113978442293169,IRF1,1
DELACROIX_RARG_BOUND_MEF,DELACROIX_RARG_BOUND_MEF,1/16,367/21728,0.23864358719309198,0.25002505058230096,0.11284846552288724,TNFRSF11B,1
REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1/16,377/21728,0.24432837454882528,0.2555877466478495,0.1153591808040375,HLA-F,1
MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,1/16,382/21728,0.24715582239816436,0.25814894946802136,0.11651517620320309,ISG20,1
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,1/16,383/21728,0.24772012047937997,0.2583421164570563,0.11660236186020627,PTGS1,1
WANG_TUMOR_INVASIVENESS_UP,WANG_TUMOR_INVASIVENESS_UP,1/16,384/21728,0.24828402200537325,0.25853427979458593,0.11668909452047159,IFITM3,1
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,1/16,385/21728,0.2488475272362537,0.2587254443479218,0.11677537638085349,ISG20,1
HAN_SATB1_TARGETS_DN,HAN_SATB1_TARGETS_DN,1/16,388/21728,0.2505356677569348,0.26008352094889114,0.11738834240215816,BST2,1
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP,1/16,392/21728,0.25278098940519,0.2620149981505851,0.11826011200242807,PLSCR1,1
OSMAN_BLADDER_CANCER_UP,OSMAN_BLADDER_CANCER_UP,1/16,401/21728,0.25780992643113476,0.26682151960425954,0.12042952890400153,PLSCR1,1
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,1/16,403/21728,0.25892315050600245,0.2675670189599206,0.12076600902124865,IFITM3,1
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,1/16,405/21728,0.26003480904856546,0.2683086438819289,0.12110074041815172,TNFRSF11B,1
REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,1/16,407/21728,0.26114490411385893,0.2690464140719182,0.12143373198701618,TNFRSF11B,1
MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,1/16,408/21728,0.2616993659840421,0.26921037497754174,0.12150773551811143,PTGS1,1
PEDRIOLI_MIR31_TARGETS_DN,PEDRIOLI_MIR31_TARGETS_DN,1/16,412/21728,0.2639133150275973,0.27107838240391213,0.12235085812186776,TMEM140,1
FOSTER_TOLERANT_MACROPHAGE_DN,FOSTER_TOLERANT_MACROPHAGE_DN,1/16,414/21728,0.26501795406969375,0.27180305229135765,0.12267793688704912,CH25H,1
LIM_MAMMARY_STEM_CELL_DN,LIM_MAMMARY_STEM_CELL_DN,1/16,416/21728,0.26612103885121163,0.27252395106417315,0.12300331356478639,ISG20,1
RUTELLA_RESPONSE_TO_HGF_UP,RUTELLA_RESPONSE_TO_HGF_UP,1/16,422/21728,0.2694209880327537,0.2754890283037617,0.12434159713223344,CXCL10,1
OSMAN_BLADDER_CANCER_DN,OSMAN_BLADDER_CANCER_DN,1/16,427/21728,0.27216031383682104,0.2778728241722266,0.12541752014574567,ISG20,1
MILI_PSEUDOPODIA_CHEMOTAXIS_DN,MILI_PSEUDOPODIA_CHEMOTAXIS_DN,1/16,428/21728,0.27270702220631604,0.2780141947941635,0.12548132758311423,PTGS1,1
REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,1/16,432/21728,0.2748900081552573,0.27982077063337857,0.12629672312380638,FGF20,1
RIGGI_EWING_SARCOMA_PROGENITOR_UP,RIGGI_EWING_SARCOMA_PROGENITOR_UP,1/16,434/21728,0.2759791961514655,0.28051019787932535,0.12660789517082155,BST2,1
VECCHI_GASTRIC_CANCER_EARLY_UP,VECCHI_GASTRIC_CANCER_EARLY_UP,1/16,436/21728,0.27706685018830024,0.28119601338037625,0.12691743706170472,IFITM3,1
DELYS_THYROID_CANCER_UP,DELYS_THYROID_CANCER_UP,1/16,445/21728,0.28194236461701316,0.28529383403296577,0.12876698282344232,HP,1
RATTENBACHER_BOUND_BY_CELF1,RATTENBACHER_BOUND_BY_CELF1,1/16,445/21728,0.28194236461701316,0.28529383403296577,0.12876698282344232,SP100,1
SENESE_HDAC1_TARGETS_UP,SENESE_HDAC1_TARGETS_UP,1/16,451/21728,0.2851755636486738,0.2881373276628292,0.13005038979449127,TNFRSF11B,1
ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,1/16,454/21728,0.2867870402626116,0.28933625839827926,0.13059152554648357,CXCL10,1
REACTOME_GPCR_LIGAND_BINDING,REACTOME_GPCR_LIGAND_BINDING,1/16,463/21728,0.29160105926037594,0.2933239606444845,0.1323913695157114,CXCL10,1
REACTOME_SIGNALING_BY_INTERLEUKINS,REACTOME_SIGNALING_BY_INTERLEUKINS,1/16,463/21728,0.29160105926037594,0.2933239606444845,0.1323913695157114,CXCL10,1
GARY_CD5_TARGETS_UP,GARY_CD5_TARGETS_UP,1/16,474/21728,0.29744349190072206,0.29875961354630043,0.13484474403820967,IRF1,1
JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,1/16,476/21728,0.2985008869615752,0.2993801237420216,0.13512481046861477,DEPP1,1
MEISSNER_NPC_HCP_WITH_H3K4ME2,MEISSNER_NPC_HCP_WITH_H3K4ME2,1/16,493/21728,0.3074286983900094,0.30788079941705354,0.1389615788388278,CH25H,1
ZHENG_BOUND_BY_FOXP3,ZHENG_BOUND_BY_FOXP3,1/16,496/21728,0.3089930941522667,0.3089930941522667,0.13946361155029274,SP100,1
